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ABSTRACT 
 
Disinfection of drinking water stands among the greatest public health achievements in 
human history. Killing or inactivation of pathogenic microbes by chemical oxidants such as 
chlorine, chloramine, or ozone have greatly reduced incidence of waterborne diseases. However, 
the disinfectant also reacts with organic and inorganic matter in the source water and generates a 
mixture of toxic disinfection byproducts (DBPs) as an unintended consequence. Since they were 
first discovered in 1974, over 600 individual DBPs have been detected in disinfected water. 
Exposure to DBPs is associated with increased risks for developing cancers of the colon, rectum, 
and bladder, and also for adverse pregnancy outcomes including small for gestational age and 
congenital malformations. While individual DBPs are teratogenic or carcinogenic, because they 
are formed at low concentrations during disinfection, it is unlikely that any one DBP can account 
for these increased risks. While genotoxicity and oxidative stress have been suggested, the 
mechanisms connecting DBP exposures to adverse health and pregnancy outcomes remain 
unknown. Investigating mechanisms of toxicity for individual, or classes of DBPs will provide a 
better understanding of how multiple DBPs interact to generate adverse health and pregnancy 
outcomes.  
Monohalogenated acetic acids (monoHAAs) iodoacetic acid (IAA), bromoacetic acid 
(BAA), and chloroacetic acid (CAA) are genotoxic and mutagenic with the consistent rank order 
of toxicity of IAA > BAA > CAA. The comparative toxicity of these compounds was highly 
correlated with their SN2 reactivity. The working hypothesis that monoHAAs were directly 
alkylating DNA was tested and rejected when no damage accumulated in acellular DNA. 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was investigated as a possible molecular 
target for the monoHAAs; each of the monoHAAs inhibited GAPDH with variable efficacy. The 
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ability to inhibit GAPDH correlated strongly with multiple toxicological endpoints measured for 
the monoHAAs. Inhibition of GAPDH was known to disrupt cellular Ca
2+
 homeostasis and 
generate reactive oxygen species (ROS). The roles Ca
2+
 and ROS played in mode of genotoxic 
action for the monoHAAs were investigated.  Each of the monoHAAs generated biomarkers of 
oxidative stress, measured both with toxicogenomic analysis and with the production of an 
antioxidant response element driven reporter gene. The antioxidant butylated hydroxyanisole and 
the intracellular Ca
2+
 chelator BAPTA-AM reduced genomic DNA damage induced by each of 
the monoHAAs, supporting the hypothesis that monoHAAs induced genotoxicty by a cascade of 
events initiated by inhibition of GAPDH.  
Disruption of Ca
2+
 homeostasis was a common event in genotoxicity induced by 
bromacetonitrile (BAN) and bromoacetamide (BAM). Although the BAN and BAM act through 
depletion of glutathione and BAA acts by inhibiting GAPDH, when BAN or BAM was 
combined with BAA in a defined component, binary mixture the genotoxicity was additive. 
These data suggested that the collective action of multiple DBPs acting through different 
pathways could converge to disrupt Ca
2+
 homeostasis, generate ROS, and cause genomic DNA 
damage.  
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
 
Introduction 
Disinfection Byproducts and Human Health Risks 
Disinfection of drinking water provides an effective means of reducing outbreaks of 
diseases caused by water-borne pathogens and represents a significant public health achievement 
of the 20
th
 century [1]. However, when chemicals such as chlorine, chlorine dioxide, 
chloramines, or ozone are used to kill or inactivate pathogenic microbes they also react with 
organic matter in the source water.  Disinfection byproducts (DBPs), unintended contaminants 
formed by the reaction of disinfectant, natural organic material (NOM), and inorganic precursors 
such as iodide (I
-
) and bromide (Br
-
) in the source water, were first discovered in 1974 when 
Rook and Bellar independently discovered chloroform and other trihalomethanes (THMs) in 
chlorinated drinking water [2, 3]. In 1976 a national survey of drinking water facilities found the 
THMs were ubiquitous in chlorine disinfected water [4]. In the same year data published by the 
National Cancer Institute reported that chloroform was carcinogenic in laboratory animals [5]. 
These two discoveries prompted the United States Environmental Protection Agency (U.S. EPA) 
to pass the first DBP regulation in 1979 with the Interim Trihalomethane Rule, which set a 
maximum contamination limit (MCL) for total trihalomethanes (TTHMs), including chloroform 
Cl3CH, bromodichloromethane BrCl2CH, dibromochloromethane Br2ClCH, and bromoform 
Br3CH, at 100 µg/L  [6]. In attempt to further limit the risk associated with DBP exposure, the 
U.S. EPA extended regulation of DBPs in 1998 with the passage of the Stage I Disinfectants and 
Disinfection Byproducts (D/DBP) rule. The Stage I D/DBP rule lowered the MCL for TTHMs to 
80 µg/L, set MCLs for chlorite and bromate at 1000 µg/L and 10 µg/L respectively, and set an 
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MCL for five haloacetic acids (HAA5), including bromoacetic acid (BAA), dibromoacetic acid 
(DBAA), chloroacetic acid (CAA), dichloroacetic acid (DCAA) and trichloroacetic acid 
(TCAA), at 60 µg/L [7]. The Stage I rule required compliance with all MCLs based on a running 
annual average of all sampling areas throughout the distribution system. This allowed facilities to 
deliver water out of compliance to a portion of their distribution system as long as the average 
across the total distribution system remained in compliance. To address this problem the U.S. 
EPA passed the Stage II D/DBP rule, which maintained the MCLs set in the Stage I rule, but 
required each monitoring station to remain in compliance over a one year average [8].  
Since the discovery of the first DBPs in 1974 [2, 3] over 600 individual compounds have 
been identified in disinfected drinking water [9]. The complexity of the organic materials along 
with many other variables including, temperature, pH, concentrations of Br
-
 and I
- 
in the source 
waters, type and concentration of disinfectant used, and contact time with the disinfectant lead to 
complex mixtures of DBPs that can vary significantly among distribution systems, and also 
within a single system [10, 11]. These complex mixtures vary both in the individual chemicals 
generated as well as the concentrations in which each chemical is formed [12, 13]. A review of 
the occurrence, toxic properties, and carcinogenicity of individual DBPs is available [14]. 
Concerns over the toxicity and carcinogenicity of individual DBPs prompted several 
epidemiological studies in an attempt to evaluate the health effects of exposure to the complex 
mixture of chemicals formed by water disinfection. Many of these studies found that exposure to 
disinfected water was associated with increased risk of colon cancer [15-17], bladder cancer [18-
25], and adverse pregnancy outcomes including small for gestational age and premature delivery 
[26-28]. The U.S. EPA estimated that the population risk attributed to chlorinated water 
accounted for 2% - 17% bladder cancer cases in the United States (US) [29]. However, based on 
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animal carcinogenicity data, none of the regulated DBPs can account for the increased bladder 
cancer risk seen in the epidemiologic studies [30]. Thus, a gap in the knowledge connecting DBP 
exposure to adverse health and pregnancy risk persists.  
While disinfection of drinking water has doubtlessly increased life expectancy and 
quality of life by preventing acute disease caused by pathogens in untreated water, the use of 
disinfectants created a situation in which virtually all of the population in the developed world is 
chronically exposed to complex mixtures of chemicals with known adverse health outcomes. 
While the induction of genotoxicity and oxidative stress among others were proposed, the 
mechanisms linking toxicity of individual or total DBP exposure to increased risks of cancer or 
adverse pregnancy outcomes are not defined [31]. Additional research is needed to identify the 
specific causes of these adverse effects. Understanding the mechanisms by which individual 
DBPs induce their toxic effects is essential to gain insight into additive or synergistic effects and 
might more accurately account for measured adverse health effects associated with disinfected 
water. Identification of cellular mechanisms of DBP-mediated toxicity may also help to identify 
populations susceptible to the effects of exposure due to genetic polymorphisms of specific 
genes (e.g. those involved in metabolic function, DNA repair, and/or responses to oxidative 
stress). 
 
Haloacetic Acids 
One of the most abundant classes of DBP found in disinfected water is the haloacetic 
acids (HAAs) [10, 12]. HAAs were the second most prevalent class of DBP, accounting for   
15.4 % of the total organic halide (TOX) fraction extracted from chlorinated drinking water, and 
the most prevalent class in chloraminated water, accounting for 15.4% of the TOX fraction [10]. 
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The di- and tri-halogenated acetic acids with multiple chlorine, or mixed chlorine and bromine 
substituted species are generally the most abundant, however, in source waters with high Br
-
 and 
I
-
, brominated DBPs can be the dominant species [13]. In a survey of 12 water distribution plants 
in the US described as having high precursor loads, the sum of 9 HAAs (HAA9) (including 
CAA, DCAA, TCAA, BAA, DBAA, tribromo (TBAA), bromochloro (BCAA), bromodichloro 
(BDCAA), and dichlorobromoacetic (DCBAA) acids) ranged from 5 µg/L to 130 µg/L with a 
median of 34 µg/L [13].  A survey of drinking water in 11 provinces in Spain found a median 
HAA9 concentration of 29.0 µg/L (ranging from 18.9 µg/L to 53.1 µg/L); in these samples CAA 
and BAA were below detection limits of 2 µg/L and 1 µg/L, respectively and iodoacetic acid 
(IAA) was not measured [32]. The sum of 6 HAAs including TCAA, BCAA, BCAA, DBAA, 
DBCAA, BAA were measured in 3 regions in England, the mean for each system was 35.1 µg/L, 
52.1 µg/L, and 94.6 µg/L with a maximum measurement of 244 µg/L; mean BAA concentrations 
were 2.6 µg/L, 4.0 µg/L, and 1.7 µg/L with a maximum of 17 µg/L [33]. Neither CAA nor IAA 
was measured in this study. In Pearl River Delta cities Guangzhou, Foshan, and Zhuhai  in 
Gangduong Province China HAA9 ranged from 0.3 – 81.3 µg/L with DCAA and TCAA being 
the most abundant species; CAA was below the detection limit (2 µg/L) in all waters sampled 
[34].   
IAA was first discovered in drinking water in a nationwide occurrence study in the US 
[13], however only limited data are available for its occurrence. One recent survey of DBP 
occurrence in Chinese water systems included measurements for IAA. Wie et al investigated 13 
drinking water plants in Shanghai China, all of which used chloramines as the primary 
disinfectant, whose source waters were the Yangtze or Huangpu rivers [35]. In these waster 
systems HAA9 ranged from 3.31 µg/L to 48.55 µg/L; IAA was detected in all systems ranging 
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from 0.04 µg/L to 1.66 µg/L [35]. The maximum IAA concentration (1.66 µg/L) occurred in 
chloraminated water sourced from the Huangpu River, which had high I
-
 concentrations (up to 
18 µg/L) relative to the Yangtze [35].  
Each of the five regulated HAAs (CAA, DCAA, TCAA, BAA, and DBAA) was 
mugagenic in Salmonella typumirium [36], genotoxic in Chinese hamster ovary cells [37], and 
teratogenic in whole mouse embryo cultures [38].  DCAA [39-41], TCAA [40], and DBAA [42] 
were carcinogenic in rodent bioassays, but CAA was not [43, 44]. No carcinogenicity data are 
presently available for BAA despite its status as a regulated compound.  
 In vitro studies showed that BAA was consistently more toxic than DBAA, and CAA 
was more toxic than DCAA and TCAA, indicating that the monoHAAs are more toxic then their 
di or tri halogenated analogues [36-38]. Comparative studies also showed a consistent trend 
among the monoHAAs where IAA is the most and CAA is the least toxic, indicating that the 
halogen substituent plays an important role in toxicity [36, 38, 45, 46].  
The focus of this research is on the HAAs with a single halogen substituent, including 
IAA, BAA, and CAA which will be referred to collectively as monoHAAs. The structures of the 
monoHAAs are displayed in Figure 1.1. While di- and tri-substituted haloacetic acids were the 
largest component of the total HAA fraction [32, 34, 47, 48], the monoHAAs were the most 
genotoxic [49] and teratogenic [38, 45] when comparative analyses were performed. 
Additionally IAA and BAA were the most mutagenic of the HAAs. By focusing on the 
monoHAAs, the mechanism(s) of toxicity can be evaluated in a series of 3 compounds with a 
single variable in the chemical structures and the role the halogen substituent plays in toxicity 
can be assessed. The toxicity of the monoHAAs reported in the literature is reviewed below. 
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Because DBP exposures are associated with cancer and adverse pregnancy outcomes, the toxic 
endpoints included in the review were limited to those relevant to these epidemiologic endpoints.  
 
Genotoxicity, Mutagenicity, and Carcinogenicity of the monoHAAs 
Mutagenicity 
Analyses of mutagenicity associated with CAA using S. typhumirium generated mixed, 
but mostly negative results. BAA and IAA, while less studied, were consistently positive as 
direct-acting mutagens S. typhumirium. Each of the monoHAAs was mutagenic in mammalian 
cells, although data are limited. Table 1.1 summarizes the results of published mutagenicity 
assays involving the monoHAAs.   
 
Salmonella Typhumirium Mutagenicity 
CAA did not significantly increase mutation frequencies in S. typhumirium tester strain 
TA 1535 [50]. Additionally, CAA was negative in the presence and absence of exogenous 
metabolic  (S9) activation in S. typhumirium strains TA100, TA 98, TA1535, and TA 1537 [51].  
Conversely,  using a modified suspension assay Kargalioglu et al reported that CAA increased 
mutations in Salmonella TA 100 with and without S9 (+ S9, 12-25 mM; -S9, 14-24  mM), and 
also in TA98 (20-28 mM) without S9 activation [36]. This study also reported that BAA was 
mutagenic in TA 98 with and without S9 (+ S9, .472 mM; -S9, 0.272 mM) and TA 100 with and 
without S9 activation (0.222 mM for both) [36]. Giller et al reported that BAA, but not CAA was 
mutagenic in TA 100 +S9 [52]. Iodoacetic acid was mutagenic in Salmonella TA 100 (>70 µM) 
[46]; the mutagenicity induced by IAA was decreased in the presence of antioxidants [53]. The 
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descending rank order in mutagenic potency among the 3 monoHAAs in TA 100 was IAA > 
BAA >> CAA (Figure 1.2) [46].  
 
Mammalian Cell Mutagenicity 
CAA with S9 was weakly mutagenic in the mouse lymphoma (L5178Y) thymidine 
kinase (Tk 
+/-
) mutation assays [54, 55]. However, at the mutagenic concentration (400 µg/mL), 
an acidic pH shift that could have influenced the results was noted [55]. Zhang et al, using the 
hypoxanthine–guanine phosphoribosyltransferase (HGPRT) gene mutation assay, showed that 
each of the monoHAAs were mutagenic in CHO K1 cells, with the rank order of mutagenicity 
being IAA > BAA > CAA [56].   
 
 Genotoxicity/DNA Damage 
DNA damage can be measured through reporter based assays in which a gene for a 
reporter protein is attached to DNA damage response element (a cis regulatory element in DNA) 
that responds to damage by increasing transcription and translation of the reporter, thereby 
producing a measurable signal in response to DNA damage. DNA damage can also be measured 
directly as strand breaks, sister chromatid exchange (SCE), chromosomal aberrations, or 
micronuclei. Only limited data are available for reporter based DNA damage assays with both 
CAA and BAA being negative. Direct measures of DNA damage generated by the monoHAAs 
are more abundant. Measures of clastogenicity were mixed for each of the monoHAAs. Each of 
the monoHAAs induced genomic DNA damage, measured by the alkaline single cell gel 
electrophoresis (SCGE) assay in multiple cell lines, suggesting that these compounds are 
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genotoxic to mammalian cells. Table 1.2 summarizes the published genotoxicity data for the 
monoHAAs.  
 
Bacteria 
CAA in the presence or absence of S9 did not activate DNA repair in the S. typhumirium 
TA1535/pSK1002 containing the umuC’-‘lacZ reporter gene [57]. Neither CAA nor BAA, at 
concentrations up to 3000 µg/mL, was positive using the SOS chromotest in the tester strain 
Escherichia coli PQ 37 [52]. 
 
Mammalian Cells 
BAA induced DNA single strand breaks measured with the alkaline elution assay in the 
murine neuroblastoma cell line L-1210 [58]. CAA did not induce DNA strand breaks in liver or 
splenocytes, or epithelial cells isolated from the stomachs or duodenums of Male Fischer 344 
rats and male B6C3Fl mice, or the human lymphoblastic cell line CCRF-CEM when measured 
with the DNA alkaline unwinding assay [59]. In the same study CAA (5 mM and 10 mM) 
induced strand breaks in primary hepatocytes isolated from the F334 rats, however, the authors 
suggested this could have been caused by acute cytotoxicity as cell viability was significantly 
decreased under the same conditions [59]. CAA did not induce chromosomal aberrations or sister 
chromatid exchanges in Chinese hamster lung fibroblasts [60]. In another study CAA without 
(but not with) S9 induced SCE in Chinese hamster ovary (CHO) cells but did not generate 
chromosomal aberrations [61]. CAA, BAA, and IAA induced chromatid, but not chromosomal 
type aberrations in primary human lymphocytes [62]. Neither CAA nor BAA generated 
micronuclei in newt (Pleurodeles wall) larvae [52]. CAA, BAA, and IAA also did not induce 
micronuclei in the human lymphoblast (TK 6) cell line [63].The sodium salt of IAA (sodium 
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iodoacetate) did not produce SCE or chromosomal aberrations in Chinese hamster lung fibroblast 
(V79) cells [64]. In another study, iodoacetate generated chromosomal aberrations in CHO cells 
with and without S9 activation, and also in TK6 cells; however, the authors concluded that the 
effects were likely associated with cytotoxicity rather than direct interaction with DNA [65]. 
CAA, BAA, and IAA induced genomic DNA damage measured with the alkaline single 
cell gel electrophoresis assay (SCGE) in CHO cells (Figure 1.3) [37, 46], in nontransformed 
human small intestine epithelial cells (line FHs 74 Int) (Figure 1.4) [66], and in primary human 
lymphocytes [62]. IAA and BAA, but not CAA generated DNA damage, measured with SCGE, 
in and in the human liver carcinoma cell line HEPG2 [67]. A study by Wei et al found that IAA 
generated genomic DNA damage in NIH 3T3 cells measured with both γH2AX staining and 
SCGE, but did not generate micronuclei [68]. Iodoacetate was genotoxic to CHO K5 cells, but 
did not induce damage to DNA isolated from CHO K5 except at the highest concentration tested 
(10 µg/mL); the authors suggested that the small but significant increase in DNA migration at 
this concentration was “fortuitous and not compound related” [69]. This finding was supported 
by an additional study which reported that none of the monoHAAs generated DNA damage in 
isolated CHO DNA, including IAA at concentrations up to 500 µM [70]. Studies that have 
quantitatively compared the genotoxicity of the monoHAAs have consistently found the 
genotoxic potency rank order to be IAA> BAA > CAA (Figures 1.3 and 1.4) [46, 62, 66, 71]. 
DNA damage induced by the monoHAAs in CHO cells was repaired under liquid holding 
conditions, suggesting that the DNA lesions were not lethal, and could be repaired [71].   
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Carcinogenicity 
Carcinogenicity data is limited for the monoHAAs. Only CAA has been tested in a 2 year 
rodent carcinogenicity assay.  CAA, in deionized water, at concentrations up to 30 mg/kg/day 
administered to F334/N rats, or at concentrations up to 100 mg/kg/day administered to B63F1 
mice by gavage generated no carcinogenic activity [44]. An additional study in which CAA at 
concentrations up to 59.9 mg/kg/day was administered to F334/N rats in drinking water also 
found no carcinogenic activity [43]. 
IAA, when applied to the skin, promoted tumors in “S” strain albino mice pretreated with 
a single application of 9,10-dimethyl-1,2 benzanthracene [72]. IAA induced malignancy in 
NIH3T3 cells with anchorage independent growth and agglutination with concavalin A [68]. The 
NIH3T3 cells transformed by IAA exposure formed fibrosarcomas after injection into Balb/c 
nude mice [68]. This study showed that IAA generated malignancy in vitro, but further 
evaluation in an in vivo cancer bioassay is needed to evaluate IAA’s status as a human 
carcinogen.  
 
Reproductive Toxicity and Teratogenicity 
In Vivo  
While DBP exposure is weakly associated with adverse pregnancy outcomes, the 
reproductive and or teratogenic effects of the monoHAAs have only scarcely been evaluated.  In 
one study, pregnant Sprague Dawley dams were given CAA (1570 ppm) in drinking water 
(average dose reported as 33 mg/rat/d) from gestational day 1 – 22, cardiac defects as well as 
changes in live/dead pups, fetal weight, placental weight, crown rump length, and external 
morphology were examined with no significant effects observed [73]. Linder et al studied the 
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acute spermatogenic effects of BAA in male Sprague Dawley rats dosed by gavage either as a 
single dose of 100 mg/kg or 14 doses of 25mg/kg/day; no significant effects were observed [74].  
Pregnant CFW mice given intramuscular injections of 0.5 mg IAA in distilled water at 
gestational day 11 or 13, or days 11-13 or 12-14 significantly increased the incidence of cleft 
palate in the pups; administration of sodium succinate (2 mg) but not sodium pyruvate (2 mg) 
reduced the effect of the IAA injection on days 11-13 [75]. Fasting the pregnant dams on 
gestational day 13, days 11-12, or days 11-13 also induced cleft palates in the pups; addition of 
IAA to the fasting did not increase cleft palate incidences, the authors of this study concluded 
that the fasting and IAA were acting at different steps of the same metabolic pathway [75]. 
Because succinate which effectively increased energy production during fasting , but not 
pyruvate, reduced the effect of treatment the authors suggested that IAA and fasting were both 
inducing their teratogenic effect by disrupting the metabolism of glucose “from the beginning of 
glycolysis to the dehydrogenation of succinate” [75].   
 
In Vitro 
In a series of in vitro whole mouse embryo studies each of the monoHAAs generated 
neural tube defects (NTD) [38, 45]. The lowest concentrations that significantly increased the 
incidences of NTD were 2.5 µM IAA [45], 6 µM BAA and 175 µM CAA [38]. In addition to 
NTD, BAA also induced rotational defects, pharyngeal arch defects and heart defects at tested 
concentrations ≥ 6 µM, somite dysmorphology at 8 µM, and eye deformations at 10 µM; CAA 
induced pharyngeal arch and heart defects at 250 µM [38]. 
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Epidemiology 
Because the HAAs have only been regulated in the US since 1998, the lack of consistent 
monitoring of HAA levels in drinking water prior to this time prevents accurate exposure 
assessment in cancer epidemiology. However, multiple human epidemiologic studies have 
evaluated the relationship between HAA exposure and adverse pregnancy outcomes [76-81], 
neural tube defects [82], or semen quality [83].  Among these only the study by Porter et al 
attempted to evaluate the relationship between single monoHAAs (CAA, and BAA) and any 
pregnancy outcome [78]. The authors reported that BAA exposures from the 3
rd
 and 4
th
 quintiles 
during 2
nd
 trimester of pregnancy resulted in significantly increased risk of intrauterine growth 
retardation (IGR) OR 1.3 (1.02- 1.65), and 1.3 (1.02-1.66), respectively; however there was no 
increased risk associated with these or any other monoHAA exposure level when evaluated over 
the entire length of the pregnancy [78]. While there was no measurement of any of the individual 
monoHAAs, the study by Klotz et al [82] was of particular interest because the endpoint they 
evaluated, neural tube defects (NTD),  had been previously associated with monoHAA exposures 
in vitro [38, 45].  Although an increase in NTD was associated with TTHMs was discovered 
when the highest (> 40 ppb) vs. the lowest (< 5 ppb) tertiles were compared, this study found no 
association with total HAA exposure during the first trimester of pregnancy and NTD [82].  
Among the studies that evaluated risk associated with total HAA exposure, only one reported 
increased risk for any adverse pregnancy outcome (small for gestational age) which was 
associated with the sum of the 5 HAAs (CAA, BAA, dichloro-, trichloro- and dibromoacetic 
acid) (HAA5) over 60 µg/L vs < 60 µg/L, OR 1.4 (1.1 – 1.9) [81]. 
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Mechanism(s) of Toxicity 
Several comparative studies that evaluated the toxicity of the monoHAAs found that 
these compounds were mutagenic in S. typhimurium [36, 46], cytotoxic and mutagenic in 
Chinese hamster ovary (CHO) K1 cells [56], cytotoxic and genotoxic in CHO AS52 cells [37, 
46, 71] genotoxic in human FHs cells [66], genotoxic in human lymphocytes [62], cytotoxic but 
not clastogenic in human TK6 cells [63], and teratogenic in in vitro whole mouse embryos [38, 
45]. In each case the rank order of toxicity was IAA > BAA > CAA.  
The monoHAAs are electrophilic alkylating agents; the electron withdrawing effects of 
the carboxylic acid functional group as well as the halogen substituent leave the carbons electron 
deficient and open for nucleophilic attack. The halogen substituent, through bond dissociation 
energy and other factors, determines the relative bimolecular nucleophilic substitution (SN2) 
reactivity of the compound, and the relative SN2 reactivity is predictive of their toxicity in 
mutagenic, genotoxic, cytotoxic, and teratogenic endpoints [46]. Essentially, the iodine is a 
better leaving group than chlorine in the SN2 reaction, which enhances the ability of the 
compound to alkylate a biological nucleophile and cause toxicity. Which biological 
nucleophile(s) is being alkylated is the focus of the remainder of the research reported in this 
dissertation.  
  
Neurotoxicity of IAA 
The neurotoxic effect of IAA has been the most rigorously studied toxicological 
mechanism among the three monoHAAs. IAA has long been known to inhibit the glycolytic 
enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [84]. An SN2 reaction between 
the electron rich thiolate sulfur and IAA’s electrophilic α-carbon results in a carboxymethylation 
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of the catalytic cysteine residue and irreversibly inhibits the enzyme’s activity [85]. The ability 
to inhibit glycolysis has made IAA a useful model to study the effects of ischemia/reperfusion 
injury in neurotoxicology.  Studies using this model of chemical ischemia show  a drop in 
cellular ATP level [86-88], an increase in cytosolic free calcium ions (Ca
2+
) [86-88], release of 
free arachidonic acid (AA) [88, 89], generation of ROS [86, 88, 90], and cell death [86, 87, 91] 
subsequent to IAA exposure. These studies have suggested that increases in cellular calcium 
levels, phospholipid degradation, and ROS formation are all critical events in the toxic cascade, 
as antioxidants [36-41], phospholipase inhibitors [40, 42], and calcium free medium or calcium 
chelators can reduce or delay the toxic response [38]. It is important to note that the rise in Ca
2+
 
generated from 100 µM IAA was from an intracellular source rather than through N-methyl-D-
aspartate (NMDA) receptor mediated Ca
2+
 influx [86, 87]. 
Free Ca
2+
 is present at very low concentrations in the cytosol (~100 nM), and a large 
gradient, roughly 20,000 fold, is maintained across the cellular membrane; additionally Ca
2+
 is 
stored in the mitochondria and endoplasmic (ER) or sarcoplasmic reticulum (SR,) again with a 
large gradient across the organellar membranes [92-94]. Maintenance of these gradients requires 
a substantial amount of energy, which, in the cell, is generally provided by hydrolysis of the high 
energy phosphoanhydride bonds in adenosine triphosphate (ATP) [93]. Glycolytic enzymes were 
found coordinated on the SR membrane and provided ATP derived specifically from glycolysis 
in the proximity of the ER/SR calcium ATPase (SERCA), a pump responsible for maintaining 
Ca
2+
 homeostasis within the ER/SR [95]. SERCA activity was significantly reduced after 
exposing cardiac myocytes or isolated SR preparations to IAA [95]. In this study, addition of 
exogenous ATP or phosphoenolpyruvate, a glycolytic intermediate (downstream of GAPDH) 
restored SERCA activity, suggesting it was not directly inhibited by IAA [95]. These findings 
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were supported in a neuronal cell model when Ca
2+
 leaked from the ER of hippocampal neurons 
after exposure to glycolytic inhibitors including IAA [96]. The Ca
2+
 specific intracellular 
chelator, 1,2- bis(2-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid tetrakis (acetoxymethyl 
ester) (BAPTA-AM), reduced the production of ROS and neuronal cell death associated with 
IAA exposure, suggesting a relationship between a rise in intracellular Ca
2+
 and oxidative stress 
[86, 87].   Taken together, these findings, at least in theory, provided a functional connection 
between inhibition of glycolysis, Ca
2+
 leakage from ER, and the generation of ROS and 
suggested that toxicity associated with IAA might be due to inhibition of SERCA. In support of 
this hypothesis, thapsigargin, a specific irreversible inhibitor of SERCA, resulted in the release 
of free AA [97, 98], and induced the formation of ROS [98], events also present in the toxic 
cascade initiated by IAA in neurons. Thapsigargin also did not potentiate the neurotoxic effect of 
IAA, again suggesting that the two chemicals were working at different steps in the same 
pathway [87]. 
 
Mutagenicity/Genotoxicity and Teratogenicity 
When BAA generated strand breaks in mouse lymphoma cells, the authors hypothesized 
that direct alkylation of DNA could be responsible [58]. These data agreed with the high 
correlation of DNA damage induced by the monoHAAs with their respective alkylating 
potentials [46]. In Salmonella and other biosystems, where the monoHAAs were mutagenic 
without metabolic activation (by definition direct-acting), seemed to agree that a direct alkylation 
of DNA might be occurring, or at least the monoHAA, rather than some metabolic byproduct, 
was responsible for toxicity. The authors suggested cytotoxicity, rather than direct alkylation, 
was responsible for the damaged DNA in study in which iodoacetate induced chromosomal 
 16 
 
aberrations, [65]. Kiffe et al designed a set of experiments to determine if iodoacetate was 
directly alkylating DNA using the standard alkaline SCGE assay and a modified version of 
SCGE in which the cells were lysed before exposure leaving only the DNA to interact with the 
toxicant [69]. CHO K5 cells exposed to iodoacetate accumulated significant damage in their 
DNA; however, the acellular DNA did not [69]. These data suggested that IAA did not directly 
alkylate DNA and that some cellular process was required for iodoacetate to generate 
genotoxicity. However, the high correlation between genomic DNA damage and alkylating 
potential suggested that alkylation of some cellular component was involved in the origin of the 
genotoxicity [46]. 
Reactive oxygen species (ROS), especially hydroxyl radical (OH∙), can react with DNA 
resulting in lesions such as 8-hydroxydeoxyguanosine (8-OH-dG) making the generation of ROS 
a viable source of mutagenicity and genotoxicity [99, 100]. Malondialdeyde (MDA), a product of 
lipid peroxidation and a byproduct of ROS production, was also mutagenic [101]. Organic 
extracts from chlorinated water increased MDA concentrations and reduced levels of glutathione 
(GSH), a major component of the antioxidant defense system, in human liver cells; these 
observations suggested that these extracts were generating oxidative stress [102, 103]. In these 
studies both MDA and GSH measurements were highly correlated with DNA damage [102, 
103]. In another study, chlorination of drinking water increased oxidative stress measured by 
activation of a reporter gene attached to an antioxidant response element (ARE) [104]. Cemeli et 
al, found that the antioxidant enzyme catalase, as well as the radical scavenger butylated 
hydroxyanisol, reduced the mutagenicity and genotoxicity of IAA, suggesting that ROS might be 
involved DNA damage and mutagenicity associated with this toxicant [53]. Two toxicogenomic 
analyses also suggested a role for ROS in monoHAA induced toxicity, when it was discovered 
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that each of the monoHAAs altered transcription of genes associated with DNA double strand 
breaks [66, 105].  Alkylated bases generally do not result in double strand breaks prior to 
replication [106]. ROS, however, are known to generate DNA double strand breaks, as highly 
reactive hydroxyl radicals are formed from H2O2 via the Fenton reaction catalyzed by metal ions 
present in DNA induce strand breaks [107]. The localization effect of the metal ions and the 
reactivity of the hydroxyl radical create hotspots where multiple lesions are likely to occur in 
close proximity of the metal ion, thus two single events have an increased probability of 
generating a double strand breaks [107].  
ROS can also negatively impact fetal development by altering critical signaling pathways 
through oxidation [59]. Oxidative stress during organogenesis modifies redox-regulated 
transcription factors and consequently modifies gene expression during development [108]. 
Biomarkers of oxidative stress such as 8-OH-dG and MDA found in the urine of pregnant 
women were associated with decreased birth weight and premature delivery [109] as well as 
small for gestational age [110], outcomes which have also been associated with DBP exposure. 
The teratogenic effect of IAA was mirrored by exposure to 2-deoxyglucose (2DG) a competitive 
inhibitor of glycolysis and also by fasting pregnant dams , indicating that disrupting the 
glycolytic pathway has a detrimental effect on fetal development [45, 75]. 
IAA induces a toxic cascade in neurons that is initiated by the inhibition of GAPDH. 
Subsequent to GAPDH inhibition ATP levels drop leading to an inability to maintain Ca
2+
 
gradients, which in turn leads to the formation of ROS, phospholipid degradation, and ends in 
neuronal death [86-89]. Disruption of glycolysis also seems to be an important factor in 
monoHAA induced teratogenicity [38, 45]. It is not clear that all cell types are equally 
susceptible to GAPDH inhibition. For instance, Kumagai et al  showed that CHO K1 cells were 
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less susceptible than cancer cell lines, which are highly dependent on glycolysis, to toxicity 
induced by koningic acid, a potent inhibitor of GAPDH [111]. We previously demonstrated that 
the HAAs, including IAA, induce toxicity in CHO AS52 cells [37, 46]. However, it remains to 
be determined if the same toxic cascade observed in IAA induced neurotoxicity is involved in 
the genotoxic/mutagenic responses induced by each of the monoHAAs in the mammalian and 
bacterial cell models used in our laboratory. The research described herein attempts to address 
these knowledge gaps and to explore how the monoHAAs generate their toxic responses, and 
more importantly how these compounds contribute to known adverse health effects associated 
with disinfected water.   
 
Rationale for Research 
Exposure to DBPs is an unintended but necessary consequence of drinking water 
disinfection. While greatly reducing the acute risk of exposure to water-borne pathogens [1], 
epidemiologic studies suggest that disinfecting water increases the risk of bladder [18-25] and 
colon cancers [15-17] and adverse pregnancy outcomes [26-28]. Although genotoxicity and 
oxidative stress were proposed [31], there is no clear mechanism leading from exposure to these 
adverse health and pregnancy outcomes. Additionally the modes of action for the toxicity of 
many individual DBPs have not been defined. None of the DBPs that were carcinogenic in 
rodent assays generated bladder cancer and the concentrations that generated neoplasms were 
much higher than those that would occur through drinking water [30]. Additional research into 
the toxic mechanisms of individual DBPs would reduce the current knowledge gap between DBP 
exposure and the associated health outcomes by defining possible areas of additivity among 
multiple components of the total DBP exposure. The HAAs were a significant fraction of the 
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total DBP pool [13]. Within the larger class of HAAs, the monoHAAs were consistently the 
most toxic [37, 38, 45, 46]. These compounds are electrophilic, and their relative SN2 reactivity 
was predictive of their toxicity, that is, in the case of both reactivity and toxicity the rank order is 
IAA > BAA > CAA [46]. The biological nucleophile(s) with which they interact are not clearly 
defined. Some studies suggested that IAA induced neurotoxicity by specifically inhibiting 
GAPDH, which then leads to an increase in cytosolic Ca
2+
, free AA, and the generation of ROS 
[86, 88].  Additionally, the mutagenicity and genotoxicity associated with IAA seems to involve 
ROS [33]. The hypothesis that each of the monoHAAs generates genotoxicity by inhibiting 
GAPDH was investigated in the research reported in this dissertation. Additionally the 
involvement of Ca
2+ 
and ROS in the manifestation of DNA damage was evaluated.    
 
Research Objectives 
In an effort to test the hypothesis that the monoHAAs induce genomic DNA damage by 
inhibiting GAPDH, which then initiates an increase of free Ca
2+
 in the cytosol triggering the 
formation of ROS the following experiments were conducted: 
  Analyze the induction of genomic DNA damage on acellular DNA for each of the 
monoHAAs. (Chapter 2)  
 Measure GAPDH enzyme kinetics in the presence and absence of each monoHAA. 
(Chapter 2) 
 Investigate the cellular response to monoHAA exposure using the ARE-bla HepG2 
Reporter Gene Assay.  (Chapter 3) 
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 Investigate cellular responses to monoHAA exposure with toxicogenomic analysis using 
a Human Oxidative Stress and Antioxidant Defense pathway specific PCR array.  
(Chapter 3) 
 Evaluate genotoxicity in CHO cells treated with individual monoHAAs in the presence 
and absence of the antioxidant butylated hydroxyanisole (BHA). (Chapter 4) 
 Evaluate genotoxicity in CHO cells treated with individual monoHAAs in the presence 
and absence of the intracellular Ca
2+
 chelator BAPTA-AM. (Chapter 4) 
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Tables and Figures 
 
 
Table 1.1. Summary of published monoHAA mutagenicity assay results. 
Chemical Biosystem Genetic Endpoint Lowest Genotoxic Concentration  Ref 
CAA Salmonella TA 1535 (-S9) His Reversion Negative  50 
 Salmonella TA 98, TA 100,                
TA 1535, TA 1537 
His Reversion Negative in all strains ± S9 51 
 Samonella TA 98, TA 100 His Reversion TA 98 -S9, 20 mM; +S9, Negative                                                           
TA 100 -S9, 14 mM; + S9, 12 mM 
36 
 Salmonella TA 100 His Reversion TA 100 -S9, negative; +S9, 20 µg/mL 52 
 L5178Y/Tk+/- Tk+/- → TK-/- positive +S9 54 
 L5178Y/Tk+/- Tk+/- → TK-/- 400 µg/mL 55 
 CHO K1 HGPRT 1 mM 56 
     
BAA Salmonella TA 100 His Reversion TA 100 -S9, negative; + S9, 20 µg/mL    52 
 CHO K1 HGPRT 800 µM 56 
 Salmonella TA 100 His Reversion TA 98 -S9, 0.272 mM; + S9, 0.472 mM                     
TA 100 -S9, 0.222 mM; + S9, 0.222 mM  
36
     
IAA Salmonella TA 100 his reversion TA 100 -S9, 70 µM 46 
 CHO K1 HGPRT 30 µM 56 
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Table 1.2. Summary of published monoHAA genotoxicity assay results. 
Chemical Biosystem Genetic Endpoint Lowest Genotoxic 
Concentration                                                             
or Genotoxic Potency (GP) 
Ref 
CAA S. typhimirium 
TA1535/pSK1002  
umuC'-'LacZ Negative  ± S9 57 
 Escherichia coli PQ 37  SOS chromotest Negative  ± S9 52 
 CCRF-CEM  DNA Strand Breaks 
(DAUA
1
) 
Negative 59 
 B6C3F1 mice (liver, 
splenocytes, 
stomach/duodenal epithelial 
cells) 
DNA Strand Breaks 
(DAUA) 
Negative 59 
 F334 rats (liver) DNA Strand Breaks 
(DAUA) 
Negative 59 
 F334 rat primary hepatocytes DNA Strand Breaks 
(DAUA) 
5 mM  59 
 Chinese hamster lung 
fibroblasts 
Chromosome aberrations                  
SCE
2 
Negative 
Negative 
60 
 CHO Chromosome aberrations Negative 61 
 CHO SCE
 
-S9, 160 µg/mL; 
 +S9 Negative 
61 
 Primary human lymphocytes Chromatid aberrations                                                                
Chromosome aberrations 
180 µM                                                                     
Negative 
62
 Pleurodeles walll larvae 
(newt) 
Micronuclei Negative 52 
 TK6 Micronuclei Negative 63 
 CHO AS52 SCGE 0.411 mM (GP) 37 
 FHs 74 Int SCGE 1.04 mM (20% Tail DNA) 66 
 Primary human lymphocytes SCGE 805.8 µM (GP) 62 
 HEPG2 SCGE Negative 67 
 CHO AS52 Acellular DNA SCGE Negative 70 
     
BAA Escherichia coli PQ 37  SOS chromotest Negative  ± S9 52 
 L-1210  DNA Strand Breaks 
(DAUA) 
100 µM 58 
 Human Lymphocytes Chromatid aberrations                                                                
Chromosome aberrations 
4 µM                                                                     
Negative 
62
 Pleurodeles walll larvae 
(newt) 
Micronuclei Negative 52 
 TK6 Micronuclei Negative 63 
 CHO AS52 SCGE 0.017 mM (GP) 37 
 FHs 74 Int SCGE 23.8 uM (20% Tail DNA) 66 
 Human Lymphocytes SCGE 12.07 µM (GP) 62 
 CHO AS52 DNA SCGE Negative 70 
 HEPG2 SCGE 0.1 µM 67 
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Table 1.2. (cont.) 
 CHO AS52 Acellular DNA SCGE Negative 70 
     
IAA TK6 (toxicity) Chromosome aberrations 20 µM 65 
 CHO (clone WBL)  Chromosome aberrations 40 µM 65 
 TK6 SCE Negative 63 
 Human Lymphocytes Chromatid aberrations                                                                
Chromosome aberrations 
45 µM                                                                     
Negative 
62
 Chinese hamster lung 
fibroblast  (V79) cells 
3
 
SCE 
Chromosome aberrations 
Negative                                                                 
Negative 
64 
 NIH3T3 Micronuclei Negative 68 
 CHO AS52 SCGE 8.7 µM (GP) 46 
 FHs 74 Int SCGE 5.9 uM (20% Tail DNA) 66 
 Human Lymphocytes SCGE 10.43 µM (GP) 62 
 HEPG2 SCGE 0.01 µM 67 
 NIH3T3 SCGE                                                             
γ-H2AX                  
3 µM                                                          
2µM  
68
 CHO K5 
3
 SCGE 0.625, 2.5, 5, and 10 µg/mL 69 
 CHO K5 Acellular DNA 
3
 SCGE 10 µg/mL (not compound 
related) 
69 
 CHO AS52 Acellular DNA SCGE Negative 70 
 
1 
DNA alkaline unwinding assay (DAUA); 
2
 Sister chromatid exchange (SCE); 3Sodium iodoacetate used in place of 
IAA.
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Figure 1.1. Structures of the monoHAAs.   
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Figure 1.2. Concentration-response curves illustrating the relative mutagenicity of iodoacetic, 
bromoacetic, and chloroacetic acids in S. typhimurium strain TA100 [46]. 
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Figure 1.3. Concentration-response curves illustrating the relative levels of genomic DNA 
damage induced by iodoacetic, bromoacetic, and chloroacetic acids [46]. 
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Figure 1.4. SCGE genotoxicity of the monoHAAs in human FHs cells [66]. 
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 1Reprinted with permission from: Pals, J.; Ang, J.; Wagner, E. D.; Plewa, M. J., Biological mechanism for 
the toxicity of haloacetic acid drinking water disinfection byproducts. Environ. Sci. Technol. 2011, 45, 
5791–5797. Copyright 2011 American Chemical Society. 
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CHAPTER 2:  BIOLOGICAL MECHANISM FOR THE TOXICITY OF HALOACETIC 
ACID DRINKING WATER DISINFECTION BYPRODUCTS
1 
  
 
 
Preface 
 This research was published: Pals, J.; Ang, J.; Wagner, E. D.; Plewa, M. J., Biological 
mechanism for the toxicity of haloacetic acid drinking water disinfection byproducts. Environ. 
Sci. Technol. 2011, 45, 5791–5797.  
Introduction 
Disinfection of drinking water is effective in reducing outbreaks of waterborne disease 
and was a public health triumph of the twentieth century [1]. However, during the disinfection 
process, toxic disinfection byproducts (DBPs) are unintentionally formed [2, 3]. Many DBPs are 
cytotoxic and genotoxic [3, 4]. Recent epidemiological studies demonstrated an association 
between exposure to DBPs and bladder cancer [5-7] or colon cancer [8]. The U.S. Environmental 
Protection Agency (U.S. EPA) suggested that 2 to 17% of urinary bladder cancer cases could be 
induced by DBPs [9]. Recent meta-analyses linked exposure to disinfected water with adverse 
pregnancy outcomes [10].  
The haloacetic acids (HAAs) are the second-most prevalent DBP class generated in 
disinfected water [11-14]. The HAAs are mutagenic in Salmonella typhimurium [15], cytotoxic 
and mutagenic in Chinese hamster ovary (CHO) K1 cells [16], cytotoxic and genotoxic in CHO 
AS52 cells [17-19], and in non-transformed human FHs cells [20], cytotoxic but not clastogenic 
in human TK6 cells [21] and teratogenic [22, 23]. In an effort to limit exposure, the U.S. EPA 
established a maximum contaminant level of 60 µg/L for the combination of 5 HAAs: 
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chloroacetic acid (CAA), dichloroacetic acid, trichloroacetic acid, bromoacetic acid (BAA), and 
dibromoacetic acid [24].  
The HAAs with a single halogen substituent (monoHAAs) include iodoacetic acid (IAA), 
BAA, and CAA. The level of toxicity induced by the monoHAAs follows the trend of IAA > 
BAA >> CAA [15, 16, 18-20, 22]. Recent attention has been focused on the occurrence and 
analytical chemistry of iodoacid DBPs by the Water Research Foundation [25]. The monoHAAs 
are alkylating agents able to undergo SN2 reactions (Table 2.1). The relative SN2 reactivity of the 
monoHAAs expressed a high correlation with cytotoxicity and genotoxicity in both S. 
typhimurium and mammalian cells [18]. However, the biological molecule(s) with which the 
HAAs react with and the mechanism(s) by which they induce toxicity remain unclear. The 
HAAs are considered direct-acting genotoxins because they are mutagenic in S. typhimurium 
without hepatic microsomal (S9) activation [3, 15]. They induce genomic DNA damage and 
mutagenicity in CHO cells without exogenous cytochrome P450 activation [16-18]. However, 
evidence is emerging that HAAs may not directly interact with genomic DNA. Elevated levels of 
8-hydroxydeoxyguanosine in mice treated with chlorinated or brominated HAAs [26-28] suggest 
that HAA-mediated generation of reactive oxygen species (ROS) are involved in the induction of 
toxicity and DNA damage. Earlier we demonstrated that catalase and the antioxidant butylated 
hydroxyanisole significantly reduced IAA-mediated mutagenicity in S. typhimurium and 
genotoxicity in CHO cells, further indicating that a radical species is involved in HAA-induced 
DNA damage [29]. 
In neurotoxicology, IAA is employed to induce chemical ischemia (a reduction in the 
availability of nutrients or oxygen) in neurons by inhibiting glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH, EC 1.2.1.12) leading to cell death [30-33]. The inhibition of GAPDH 
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blocks glucose metabolism to pyruvate and as a result of disruption of the electron transport 
chain, in the presence of oxygen, leads to the production of ROS [34]. Recent studies 
demonstrated that IAA-mediated neuronal damage was caused by ROS generation [30, 32]. 
Although the biochemical process leading to ROS production is not fully understood, with 
moderate IAA-mediated blockage of glycolysis, the generation of ROS is linked to calcium 
(Ca
2+
) influx through N-methyl-D-aspartate (NMDA) receptors via an excitotoxic mechanism 
[31]. However, in the same study when neurons were exposed to a higher IAA concentration, an 
intracellular source of Ca
2+ 
was implicated as the NMDA agonist MK-801 did not protect the 
cells, but BAPTA-AM, an intracellar Ca
2+
 chelator, effectively reduced toxicity [31]. 
We hypothesize that a common mechanism exists in the induction of HAA-mediated 
cytotoxicity and genotoxicity observed in bacterial, mammalian and human cells. The objective 
of this study was to determine whether or not the monoHAAs directly damage genomic DNA, 
and determine if a cellular process was required for the induction of genotoxicity in CHO cells. 
We compared the genomic DNA damaging capacity of the monoHAAs under acellular versus 
cellular conditions. In consort with this hypothesis we quantitatively measured the inhibition 
kinetics of GAPDH activity induced by the monoHAAs and compared these data with the 
induction of CHO cell cytotoxicity and genotoxicity.  
 
Materials and Methods 
Reagents   
General reagents were purchased from Fisher Scientific Co. (Itasca, IL) and Sigma 
Chemical Co. (St. Louis, MO). BAA and CAA were purchased from Fluka Chemical Co. 
(Buchs, Switzerland) while IAA was purchased from Aldrich Chemical Co. (Milwaukee, WI). 
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Glyceraldehyde 3-phosphate was purchased from Sigma-Aldrich (St. Louis, MO). Cell culture 
F12 medium and fetal bovine serum (FBS) were purchased from Fisher Scientific Co. The HAAs 
were dissolved in dimethylsulfoxide (DMSO) and stored at −22°C in sealed, sterile glass vials. 
For the GAPDH activity assay, CAA was dissolved directly into F12 medium while IAA and 
BAA were diluted from the DMSO stock solutions in Tris-HCl pH 8.5.  
 
Chinese Hamster Ovary Cells 
Clone 11-4-8 of the transgenic Chinese hamster ovary (CHO) cell line AS52 was used [4, 
35]. The cells were maintained in F12 medium containing 5% FBS, 1% antibiotic-antimycotic 
solution (Invitrogen, Carlsbad, CA), and 1% glutamine and grown in 100 mm glass culture plates 
at 37°C in a humidified atmosphere of 5% CO2. 
  
Acellular Single Cell Gel Electrophoresis 
The single cell gel electrophoresis (SCGE or Comet assay) is a sensitive method for 
measuring genomic DNA damage in individual nuclei from cells [36, 37]. In this study we 
treated acellular nuclei with monoHAAs to measure the induction of genomic damage without 
intervening cellular activity. Microgels were prepared using the method described [38]. CHO 
cells were washed twice with 10 mL Hanks’ balanced salt solution (HBSS) and harvested with 1 
mL 0.05% trypsin solution in HBSS. Trypsin activity was stopped with 2 mL of F12 +FBS 
medium and 1 mL of the cell suspension was mixed with 1 mL of 1% low melting point agarose 
prepared with phosphate buffered saline (PBS). Aliquots (90 µL) of these cell suspensions were 
placed on clear microscope slides pre-coated with 1% normal melting point agarose prepared 
with deionized water. The microgels were placed in lysing solution (2.5 M NaCl, 1% sodium 
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lauryl sarcosinate, 100 mM Na2EDTA, 10 mM Tris, pH 10 with 1% Triton X-100 and 10% 
DMSO) overnight at 4C. Lysed microgels were rinsed 2× with deionized water and submerged 
in PBS for 5 min. The microgels were treated at pH 7.4 for 2 h at room temperature in Coplin 
jars with 50 mL of BAA, CAA, or IAA dissolved in PBS. The concurrent positive control was 
15% hydrogen peroxide. After treatment, slides were rinsed twice with cold deionized water. The 
DNA was denatured for 20 min in electrophoresis buffer (1 mM Na2EDTA and 300 mM NaOH, 
pH 13.5). The SCGE microgels were electrophoresed for 40 min at 25 V, 300 mA (0.72 V/cm) at 
4C. After electrophoreses, the microgels were neutralized with 400 mM Tris buffer (pH 7.5), 
dehydrated in cold methanol for 20 min and dried for 5 min at 50C. The microgels were stored 
in the dark at room temperature. Before microscopic analyses, the microgels were hydrated in 
deionized water at 4C for 30 min, stained with 65 L of ethidium bromide (20 g/mL), and 
rinsed in cold deionized water. After staining, 25 randomly chosen nuclei per microgel were 
analyzed with a Zeiss fluorescence microscope (excitation filter of BP 546/10 nm, barrier filter 
of 590 nm) and a computerized image analysis system (Komet version 3.1, Kinetic Imaging Ltd. 
Liverpool, UK). The data were automatically transferred to an Excel spreadsheet for statistical 
analysis. The experiments were repeated 3 times. 
 
Glyceraldehyde-3-phosphate Dehydrogenase Assay 
Viable CHO cells or CHO cell homogenates were treated with monoHAAs to determine 
if they could inhibit the activity of GAPDH. CHO cells were grown to confluence on 60 × 15 
mm plastic culture plates, the cells were washed with HBSS and treated with the HAAs in F12 
medium in a total volume of 1 mL at 37°C in a humidified atmosphere of 5% CO2. After 
treatment (10 - 60 min), the medium was aspirated and the cells were homogenized according to 
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the procedure published by Chang [39]. CHO cells were washed with cold PBS followed by a 
wash with cold buffer K (1 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl2, pH 7.6). The cells 
tumefied at room temperature in buffer K for 2 min. The buffer was aspirated, 200 µL of fresh 
buffer K (20°C) was added to the dish and the cells were quickly dispatched with a cell scraper. 
The homogenate was collected into a microfuge tube, mixed, and centrifuged at 16,100 ×g for 2 
min to remove cellular debris. The supernatant fluid (CHO cell homogenate) was analyzed for 
GAPDH activity. 
The measurement of GAPDH activity was modified from Ikemoto [40]. A reaction 
mixture of 0.1 M Tris-HCl (pH 8.5) containing 5 mM KH2PO4, 20 mM NaF, 1.7 mM NaAsO2, 
and 1 mM NAD
+
 was prepared. The reaction mixture (976.3 µL) plus 20 μL of cell homogenate 
served as the blank. The GAPDH reaction was initiated by adding 1 mM glyceraldyde-3-
phospate to the reaction mixture (1 mL final volume). GAPDH activity was determined by 
measuring NADH formation as an increase of absorption at 340 nm every 10 sec for 60 sec using 
a Beckman DU 7400 UV-Vis spectrometer. Each experiment included 3 monoHAA 
concentrations and one negative control with 3 replicates for each concentration; experiments 
were repeated 3 or 4 times. Absorbance values were plotted versus time for each individual 
experiment and linear regression was conducted. Rates were calculated using the slope of the 
regression. Average rates were calculated for each concentration at each time point.  
Alternatively, untreated CHO cells were grown to confluence and homogenized as above. 
The reaction mixture was prepared using 20 μL of untreated cell homogenate; the monoHAA 
diluted in Tris-HCl was added directly to the reaction mixture (final volume 1 mL). GAPDH 
activity for cellular homogenates was measured using the procedure detailed above. Protein 
concentration for all homogenates was determined using the microplate-based Bradford assay 
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according to manufacturer’s instructions (Biorad, Hercules CA). GAPDH activity rates were 
calculated as μMol NADH/min/μg protein.  
 
Results and Discussion 
In mammalian systems, the monoHAAs have been shown to be cytotoxic, genotoxic, 
mutagenic, or teratogenic [16, 17, 20, 22]. In each case the rank order of toxicity was IAA > 
BAA >> CAA. The mechanisms that lead to this signature of toxic potency signature are not 
clear.  
 
Direct DNA Damage by MonoHAAs 
Among the monoHAAs, a close association exists amongst the halogen leaving group, 
relative alkylating potential and the induction of adverse biological endpoints measured in a 
variety of bioassays (Table 2.1) [18]. From these associations we formed a working hypothesis 
that the monoHAAs interacted directly with DNA to induce genotoxic damage. To test this 
hypothesis, we compared the induction of genomic DNA damage in treated viable cells versus 
treated isolated nuclei. Acellular SCGE analyses can determine if an agent directly induces DNA 
damage without the interaction of cellular targets or metabolism. The SCGE (Comet) assay 
effectively identifies multiple types of DNA lesions including alkylated bases. Both spontaneous 
or enzyme catalyzed loss of alkylated bases result in apurinic/apyrimidinic (AP) sites. The AP 
sites in turn may generate DNA strand breaks by spontaneous cleavage or AP endonuclease-
mediated cleavage [41]. Alkylating agents are effective in generating DNA damage in the 
acellular Comet assay [42-44]. Surprisingly, in the present study the monoHAAs did not induce 
direct genomic DNA damage in acellular nuclei. No DNA damage was observed for IAA (10 – 
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500 µM), BAA (10 – 500 µM) or CAA (1 – 10 mM) (Figure 2.1). These data rejected our 
working hypothesis that the monoHAAs directly interacted with DNA to induce genotoxic 
damage. The differential responses between the cellular and acellular SCGE analyses (Figure 
2.1) demonstrated that the monoHAAs required an interaction with a cellular target or were 
metabolized to a proximal mutagen in order to inflict genotoxic insult in mammalian cells. 
 
IAA as a Probe of GAPDH Activity 
The ability of IAA to inhibit glycolysis has been employed as a model to study the effect 
of ischemia reperfusion injury in neurons [30, 32, 33, 45-47]. After neuronal IAA exposure, ATP 
depletion [31, 33, 48], ROS generation [31, 33], phospholipid degradation [33] and neurotoxicity 
[30, 31, 33, 48] were observed. The attenuation of neurotoxicity by specific antioxidants 
suggested that ROS play a significant role in cell death [33]. 
Central to its glycolytic function is a conserved cysteine residue in the active site of 
GAPDH. This cysteine serves as a nucleophile in the first catalytic step in the conversion of 
glyceraldehyde-3-phosphate to 1,3-bis-phosphoglycerate. The α-carbon of IAA is a primary 
alkyl halide and an electrophile due to electron withdrawal from the carbon by the halogen 
substituent. IAA inhibits GAPDH when the α-carbon undergoes an SN2 reaction with the 
nucleophilic thiol group on the catalytic cysteine residue. This results in a carboxymethylated 
cysteine which irreversibly inhibits the catalytic function of the enzyme. Due to their structural 
similarity, we predicted that each of the monoHAAs would undergo a similar reaction and 
irreversibly inhibit GAPDH to varying degrees based on their SN2 reactivity. The SN2 reactivity 
of alkyl halides, including the monoHAAs, is directly related to the leaving efficiency of the 
halogen substituent, with the rank order of reactivity: IAA > BAA >> CAA. Based on this trend 
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we predicted that IAA would be the strongest inhibitor of GAPDH, followed by BAA, and CAA 
would be the weakest (Table 2.1). This prediction formed our new working hypothesis that the 
monoHAAs induced their relative toxicity profile based on their relative affinity and reactivity in 
inhibiting GAPDH. 
 
Inhibition of GAPDH Activity by MonoHAAs in CHO Cell Homogenates 
Fresh CHO cell homogenates were prepared as described previously and the activity of 
GAPDH was determined by measuring the formation of NADH. GAPDH activity was expressed 
as µmol NADH/min/µg protein. All concentrations of the monoHAAs added to the cell 
homogenates inhibited GAPDH, IAA (10 – 50 µM), BAA (50 – 150 µM) and CAA (5 – 20 
mM). The inhibition kinetics of GAPDH is presented in Figure 2.2. The slope for each inhibition 
curve taken from the linear regression of the data provided the rate of GAPDH inhibition. The 
reduction of GAPDH activity per µM monoHAA concentration (with their r
2
 values) were the 
following; IAA (−1.04×10−2, r2 = 0.99), BAA (−2.79×10−3, r2 = 0.99), and CAA (−1.81×10−5, r2 
= 0.99) (Table 2.1). With CHO cell homogenates the monoHAAs inhibited the activity of 
GAPDH in a concentration-dependent manner with a rank order of effect expressed as IAA > 
BAA >> CAA. 
 
Inhibition of GAPDH Activity by MonoHAAs in Treated CHO Cells 
To eliminate the possibility that GAPDH inhibition with cell homogenates was 
artifactual, we treated viable cells and then measured GAPDH activity in the resulting 
homogenates. CHO cells were treated with IAA (10 – 50 µM), BAA (50 – 150 µM) or CAA (1 – 
10 mM) for time periods from 10 to 60 min. Cells were washed, homogenized and the rate of 
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GAPDH activity was determined as a function of monoHAA treatment concentration and time. 
Figure 2.3 illustrates the GAPDH inhibition curves induced by BAA treatments of 10, 20, 30 or 
60 min. Analyses by linear regression demonstrated that the 20 min treatment time provided the 
widest range of linear response. The GAPDH rates as a function of monoHAA concentration and 
treatment times are presented in the Supporting Information. The GAPDH inhibition curves 
induced by a 20-min treatment of with IAA, BAA or CAA are illustrated in Figure 2.4; the r
2
 
was 0.93, 0.90 and 0.95, respectively. The reduction of GAPDH activity (µmol NADH/min/µg 
protein) per µM monoHAA concentration was IAA (−1.58×10−2), BAA (−6.74×10−3) and CAA 
(−9.44×10−5) (Table 2.1). With intact viable CHO cells the monoHAAs inhibited the activity of 
GAPDH in a concentration- and time-dependent manner with a rank order of effect expressed as 
IAA > BAA >> CAA. These data demonstrate that the inhibition of GAPDH was observed with 
monoHAA-treated viable cells and the results were not an artifact due to homogenation. 
 
Correlation of GAPDH Inhibition with MonoHAA Chemical Characteristics and Toxicity 
The objective of this research was to determine a biological mechanism for monoHAA-
mediated toxicity. To address this, we conducted multiple correlation analyses of the 
physiochemical and toxicological characteristics of these monoHAAs using the Pearson’s 
Product Moment test (Table 2.2). Data from this study, from our previous work and data 
obtained from other studies in the literature for this correlation analyses are presented in Table 
2.2. A pattern of toxic potency associated with the halogen leaving group of the monoHAAs was 
first presented in the pioneering research by Hunter and colleagues [22, 49]. Besides being 
neuro-teratogens in mice, the HAAs are cytotoxic, genotoxic, and mutagenic in a host of 
biological assays ranging from bacterial to human cell systems. In earlier work we discovered a 
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high level of correlation between the cytotoxic and genotoxic responses induced in S. 
typhimurium and CHO cells associated with the α-carbon-halogen dissociation energy, C-X bond 
length, the relative SN2 alkylating potential and the ELUMO value (lowest unoccupied molecular 
orbital) of the monoHAAs [18]. In this study we compared the GAPDH inhibition rates induced 
by the monoHAAs in cell-free homogenates and in treated viable cells with their physiochemical 
and biological characteristics. The Pearson’s Product Moment correlation for the above 
mentioned physiochemical endpoints and the rates of GAPDH inhibition were highly correlated 
(Table 2.2). The proclivity of the halogen leaving group and the monoHAA alkylation potential 
was highly associated with the rates of GAPDH inhibition. Likewise, chronic cytotoxic indexes 
in S. typhimurium (r = −0.99) or CHO cells (r = −0.99) were highly correlated with GAPDH 
inhibition (Table 2.2). The levels of mutagenicity induced by the monoHAAs in S. typhimurium 
(r ≥ −0.99), CHO cell mutagenicity (r ≥ −0.91), CHO cell genotoxicity (r ≥ −0.97), and non-
transformed human FHs cell genotoxicity (r ≥ −0.99), were all highly correlated with the rates of 
GAPDH inhibition (Table 2.2). Finally, mouse ex vivo embryo teratogenicity was also highly 
correlated with monoHAA-mediated GAPDH inhibition (r ≥ −0.98). These data strongly support 
the hypothesis that the monoHAAs exert their cytotoxic, genotoxic, mutagenic and teratogenic 
activities based on their ability to inhibit GAPDH. It has not escaped our attention that direct 
measurements based on GAPDH inhibition, ROS activity, and adverse biological responses need 
to be conducted simultaneously in order to rigorously and quantitatively test this hypothesis. 
Such research is currently being conducted in our laboratory. 
While there is a very high correlation between the inhibition of GAPDH and the 
toxicological endpoints discussed above, a direct biological link between the two continues to be 
elusive. Although repressing the glycolytic role of GAPDH is central to the induced cytotoxicity, 
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GAPDH is now known to have an overlay of diverse activities unrelated to its glycolytic 
function. GAPDH operations include membrane fusion, microtubule bundling, 
phosphotransferase activity, nuclear RNA export, DNA replication and DNA repair [50], as well 
as transcriptional control of histone gene expression, nuclear membrane fusion, recognition of 
mismatched nucleotides, and participation in maintaining telomere structure [51]. Studies on 
human single-nucleotide polymorphisms of GAPDH demonstrate that these mutations are 
associated with late-onset Alzheimer’s disease [52]. This suggests the possibility that 
subpopulations may exist with heightened risks to monoHAA-induced ROS. The role of ROS in 
toxicity is supported by the observations that antioxidants reduce neurotoxicity [31, 33] as well 
as genotoxicity and mutagenicity [29].  
The halogenated acetic acids are a major class of drinking water disinfection byproducts 
(DBPs) with 5 haloacetic acids regulated by the U.S. EPA. These agents are cytotoxic, 
genotoxic, mutagenic, and teratogenic. The decreasing toxicity rank order of the 
monohalogenated acetic acids (monoHAAs) is iodo- > bromo- >> chloroacetic acid. We present 
data that the monoHAAs inhibit glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity 
in a concentration-dependent manner with the same rank order as above. The rate of inhibition of 
GAPDH and the toxic potency of the monoHAAs are highly correlated with their alkylating 
potential and the propensity of the halogen leaving group. This strong association between 
GAPDH inhibition and the monoHAA toxic potency supports a comprehensive mechanism for 
the adverse biological effects by this widely occurring class of regulated DBPs. 
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Supporting Information 
Inhibition of GAPDH Activity by Monohaloacetic Acids  in Treated CHO Cells 
CHO cells were treated with IAA (10 – 50 µM), BAA (50 – 150 µM) or CAA (1 – 10 
mM) for time periods from 10 to 60 min. Cells were washed, homogenized and the rate of 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity was determined as a function of 
monoHAA treatment concentration and time. GAPDH activity rates were calculated as μMol 
NADH/min/μg protein. Table 2.3 presents the GAPDH rates of activity as a function of the 
monohaloacetic acid (monoHAA) concentration and treatment time.  
            From the data presented in Table 2.3 we determined the best linear responses of 
monoHAA inhibition of GAPDH were with the 20 min treatment time. These data were used to 
calculate inhibition slopes that were employed in the Pearson’s Product Moment correlation 
analyses discussed in the paper. 
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Tables and Figures 
 
 
 
 
 
 
Table 2.1. Chemical and biological characteristics of the monoHAAs. 
Mono 
HAA 
C-X ELUMO 
(AU)a 
Bond 
Lengt
h 
(Å)b 
Dissociation 
Energy 
(kcal/mol)b 
Relative 
SN2b 
Inhibition of 
GAPDH: 
CHO Cell 
Homogenate c 
Inhibition  
of GAPDH: 
Treated CHO 
Cells d 
BAA CBr 0.111 1.93 65.9 50 2.79103 6.74103 
CAA CCl 0.126 1.77 78.5 1 1.81105 9.44105 
IAA CI 0.091 2.14 57.4 150-250 1.04102 1.58102 
 
a Calculated ELUMO (lowest unoccupied molecular orbital) summarized from [53]. 
b Summarized 
from [54]. c,d The average rate of GAPDH inhibition per µM monoHAA concentration derived 
from the slope of the inhibition curves for each monoHAA presented in Figure 2.2 (treated CHO 
cell homogenates) or Figure 2.4 (treated intact CHO cells). 
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Table 2.2. Pearson correlation analyses of physiochemical and toxicological measurements of the monohaloacetic acids. 
Physicochemical 
and toxicological 
parameters 
 
CHO cell 
cytotoxic 
index 
(r)  
CHO cell 
genotoxic 
index 
(r) 
FHs cell 
genotoxic 
index 
(r) 
Salmonella 
cytotoxic 
index 
(r) 
Salmonella 
mutagenic 
potency 
(r) 
CHO cell 
mutagenicity 
index 
(r) 
Mouse 
terato- 
genicity 
(r) 
GAPDH 
inhibition 
CHO cell 
homogenate 
 (r) h 
GAPDH 
inhibition 
Treated 
CHO cells 
 (r) i 
ELUMO 
a
 0.990 0.996 0.999 0.999 0.999 0.907 0.979  0.984 0.999 
C-X bond length b  0.990  0.997  0.999  0.999  0.999  0.905  0.978 0.983 0.999 
C-X dissociation 
energy b 
0.945 0.994 0.972 0.974 0.971 0.809 0.922  0.931  0.982 
relative SN2 
alkylation potential b 
 0.998  0.959  0.988  0.986  0.988  0.973  0.999 0.999 0.979 
CHO cell cytotoxic 
index c 
---  0.976  0.996  0.995  0.996  0.956  0.998 0.999 0.990 
CHO cell genotoxic 
index d 
--- ---  0.992  0.993  0.991  0.868  0.959 0.965 0.997 
FHs human cell 
genotoxic index d 
--- --- ---  0.999  0.999  0.925  0.987 0.991 0.999 
Salmonella cytotoxic 
index c 
--- --- --- ---  0.999  0.921  0.986 0.989 0.999 
Salmonella 
mutagenic potency e 
--- --- --- --- ---  0.926  0.988 0.991 0.999 
CHO cell 
mutagenicity  f 
--- --- --- --- --- ---  0.974 0.968 0.906 
Mouse 
teratogenicity g 
--- --- --- --- --- --- --- 0.999 0.979 
 
a Calculated ELUMO (lowest unoccupied molecular orbital) summarized from [53]. 
b Summarized from [54]. c Derived as the reciprocal 
of the LC50 concentration (×constant to generate whole numbers). 
d Derived as the reciprocal of the SCGE genotoxic potency value 
(×constant to generate whole numbers). e Data from [15, 18]. f Data from [16]. g Data from [22]. 
 h,i The average rate of GAPDH inhibition per µM monoHAA concentration derived from the slope of the inhibition curves for each 
monoHAA presented in Figure 2.2 (treated CHO cell homogenates) or Figure 2.4 (treated intact CHO cells) (this study). 
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Table 2.3. GAPDH rates in treated CHO cells as a function of monoHAA concentration and exposure 
times. 
MonoHAA (µM) 
Treatment Time and GAPDH Average Rate of Activitya ±SEb 
10 min 20 min 30 min 60 min 
IAA, 0 1.053 ± 0.086 0.937 ± 0.056 0.989 ± 0.116 0.932 ± 0.178 
IAA, 10 0.930 ± 0.074 0.614 ± 0.055 0.540 ± 0.083 0.203 ± 0.026 
IAA, 25 0.905 ± 0.213 0.353 ± 0.041 0.219 ± 0.044 0.051 ± 0.006 
IAA, 50 0.546 ± 0.134 0.107 ± 0.017 0.047 ± 0.006 0.022 ± 0.004 
 
BAA, 0 1.136 ± 0.187 1.165 ± 0.160 0.990 ± 0.056 0.844 ± 0.048 
BAA, 50 0.936 ± 0.078 0.514 ± 0.077 0.242 ± 0.020 0.027 ± 0.005 
BAA, 100 0.882 ± 0.076 0.277 ± 0.034 0.065 ± 0.006 0.032 ± 0.010 
BAA, 150 0.685 ± 0.122 0.120 ± 0.021 0.030 ± 0.002 0.021 ± 0.002 
     
CAA, 0 0.946 ± 0.045 0.969 ± 0.069 0.917 ± 0.102 0.797 ± 0.009 
CAA, 1000 0.936 ± 0.058 0.837 ± 0.055 0.708 ± 0.077 0.431 ± 0.011 
CAA, 5000 0.678 ± 0.023 0.303 ± 0.061 0.155 ± 0.026 0.023 ± 0.003 
CAA, 10000 0.193 ± 0.013 0.038 ± 0.005 0.032 ± 0.004 0.019 ± 0.006 
 
a
 For each treatment time and monoHAA concentration the GAPDH rate was measured 3× and 
each experiment was repeated 3 or 4 times. GAPDH activity rates were calculated as μMol 
NADH/min/μg protein. b Standard error of the mean. 
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Figure 2.1. Induction of SCGE genotoxicity concentration-response curves for IAA, BAA and 
CAA in treated viable CHO cells (open symbols) or acellular nuclei (filled symbols). The CHO 
cell data were from [18]. 
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Figure 2.2. GAPDH inhibition curves induced by IAA, BAA, or CAA when added to freshly 
prepared CHO cell homogenates. 
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Figure 2.3. GAPDH inhibition curves expressed in CHO cells after treatments with BAA for 10, 
20, 30 or 60 min.  
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Figure 2.4. GAPDH inhibition curves expressed in CHO cells after treatments with IAA, BAA or 
CAA for 20 min. 
 
 
 
 
 
 
 
 
 
 1
Reprinted with permission from:  Pals, J.; Attene-Ramos, M. S.; Xia, M.; Wagner, E. D.; Plewa, M. J., 
Human cell toxicogenomic analysis linking reactive oxygen species to the toxicity of monohaloacetic 
Acid drinking water disinfection byproducts. Environ. Sci. Technol. 2013, 47, (21), 12514-12523.  
Copyright 2013 American Chemical Society. 
                                                                           
63 
 
CHAPTER 3:  HUMAN CELL TOXICOGENOMIC ANALYSIS LINKS REACTIVE 
OXYGEN SPECIES TO THE TOXICITY OF MONOHALOACETIC ACID DRINKING 
WATER DISINFECTION BYPRODUCTS
1 
 
Preface 
 This research was published: Pals, J.; Attene-Ramos, M. S.; Xia, M.; Wagner, E. D.; Plewa, M. 
J., Human cell toxicogenomic analysis linking reactive oxygen species to the toxicity of 
monohaloacetic Acid drinking water disinfection byproducts. Environ. Sci. Technol. 2013, 47, 
(21), 12514-12523.  
 
Introduction 
Disinfection of drinking water was a major public health achievement of the last century 
that substantially reduced outbreaks of waterborne disease [1]. During disinfection toxic 
byproducts (DBPs) are unintentionally generated when the disinfectant reacts with organic 
matter and inorganic precursors in the source water [2]. Over 600 individual DBPs have been 
identified in disinfected drinking water [3]; the mixture of DBPs generated varies depending on 
source water characteristics, disinfection method, DBP precursors and other factors [4, 5]. The 
United States Environmental Protection Agency (U.S. EPA) regulates 11 DBPs requiring 
distribution systems to monitor their levels [6]. DBP exposure increased the risk of adverse 
health outcomes including bladder cancer [7], colorectal cancer [8], and skin cancer [9]. 
Although DBP exposure during gestation was implicated in adverse pregnancy outcomes 
 64 
 
including fetal growth restriction [10-12] and congenital anomalies these associations are, at 
present, inconclusive [13].  
The U.S. EPA estimated that the population risk to chlorinated water accounted for 2% to 
17% of bladder cancer cases in the United States [14]. However, based on animal carcinogenicity 
data, the regulated DBPs, at levels measured in disinfected water, cannot account for the 
increased risk of cancer attributed to DBP exposure. This risk is possibly derived from additive 
or synergic effects of multiple DBPs [15, 16]. 
 The mechanism(s) by which DBPs induce cancer are not understood. Oxidative stress is 
one mechanism that could explain these adverse health outcomes [17]. Multiple DBPs could 
contribute to an overall oxidative imbalance within cells or tissues. Biomarkers of oxidative 
stress have been reported after exposure to individual DBPs including 3-chloro-4-
(dichloromethyl)-5-hydroxy-2-(5H)-furanone (MX) [18], bromate [19, 20], di- and 
trichloroacetate [21, 22], bromodichloroacetate, bromochloroacetate, dibromoacetate  [22], 
chloroacetonitrile [23], dichloroacetonitrile [24], and also organic extracts from disinfected 
waters [25, 26]. 
The monohalogenated acetic acid DBPs (monoHAAs), including iodoacetic acid (IAA), 
bromoacetic acid (BAA), and chloroacetic acid (CAA), are genotoxic in human cells [27] and 
Chinese hamster ovary (CHO) cells [28-30], and mutagenic in Salmonella typhimurium [31], and 
CHO cells [32]. IAA was a potent inducer of malignant transformation of NIH3T3 cells which 
were tumorigenic in nude mice [33]. IAA induced reactive oxygen species (ROS), possibly by 
inhibiting glycolysis [34] causing a reduction of pyruvate, lowering ATP levels and inducing 
mitochondrial stress. ROS-induced genotoxicity may be the mechanism for the observed 
malignancy in NIH3T3 cells [33]. The genotoxicity and mutagenicity of IAA were mitigated by 
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antioxidants [35]. Together these observations suggest that the genotoxicity and mutagenicity of 
IAA is derived from the generation of ROS. Recently we demonstrated that each monoHAA 
inhibited glycolysis by inhibiting the enzyme glyceraldehyde phosphate dehydrogenase 
(GAPDH); the inhibition kinetics strongly correlated with toxicological endpoints, suggesting a 
common mechanism for these compounds [36, 37]. 
ROS damage essential biomolecules and lead to cellular dysfunction and disease. Ageing, 
cancer, atherosclerosis, and neurodegenerative diseases are linked to oxidative stress [38]. 
Cellular response to oxidative and electrophilic stress is coordinated primarily through the redox 
sensitive transcription factor, nuclear factor E2-related factor 2 (Nrf2) [39] and antioxidant 
response elements (AREs), cis-acting factors present in the regulatory regions of 
ROS/electrophile detoxification genes [40]. This pathway allows cells to respond to oxidative or 
electrophilic stress by upregulating antioxidant genes, or genes involved in ROS detoxification. 
ARE-mediated reporter gene assays were used to screen for chemicals that induce oxidative 
stress [41] and were used as a biomarker of oxidative stress in a recent analysis of a water 
disinfection system [42]. 
The objective of this research was to gain additional information on the mechanism(s) of 
the toxicity of the monoHAAs. We employed an ARE β-lactamase reporter gene assay (ARE-bla 
assay) to determine if these compounds induce oxidative stress. Subsequently we used 
toxicogenomic analysis to determine if ROS were generated after monoHAA exposure and 
monitored specific genes associated with the generation of oxidative stress, or antioxidant 
response.  
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Materials and Methods 
Reagents 
General laboratory chemicals were purchased from Fisher Scientific Co. (Itasca, IL) or 
Sigma Chemical Co. (St. Louis, MO). Growth medium and fetal bovine serum (FBS) were 
purchased from Hyclone Laboratories (Logan, UT). Human epidermal growth factor (EGF) was 
purchased from Sigma Chemical Co., BAA and CAA were purchased from Fluka Chemical Co. 
(St. Louis, MO) IAA was purchased from Aldrich Chemical Co (St. Louis, MO).  
 
ARE-bla HepG2 Reporter Gene Assay 
The CellSensor® ARE-bla HepG2 cell line (Life Technologies, Madison, WI) contains a 
β-lactamase reporter gene under control of the Antioxidant Response Element (ARE) stably 
integrated into HepG2 cells. Cells were maintained in DMEM with glutamax (Life Technologies) 
supplemented with 10% dialyzed FBS, 0.1 mM NEAA, 25 mM HEPES, 100U/mL Penn-strep 
and 5 µg/mL blasticidin at 37°C and 5% CO2. Cells were harvested using 0.25% trypsin, 
centrifuged, and suspended in assay medium (DMEM with glutamax supplemented with 1% 
dialyzed FBS, 0.1 mM NEAA, 25 mM HEPES and 100U/mL Penn-strep). Cells were plated at 
2000/well/5 µL in 1536 well black-clear bottom plates (Greiner Bio-One North America, 
Monroe, NC) and incubated at 37°C, 5% CO2 for 5 h. Twenty-three nL of compounds or a 
positive control, β-napthoflavone, were transferred to each well using a pintool (Kalypsys, San 
Diego, CA). Cells were incubated at 37°C, 5% CO2 for 16 h. After the incubation period, 1 µL of 
CCF4 dye (Life Technologies) was added to each well and the plate was incubated at room 
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temperature for 2 h. Fluorescence intensity at 460 and 530 nm emissions was measure at 405 nm 
excitation by an Envision plate reader (PerkinElmer, Boston, MA) followed by an addition of 4 
µL/well of cell viability reagent (CellTiter-Glo, Promega, Madison, WI). The plates were 
incubated for 30 min at room temperature and luminescence was read using a ViewLux plate 
reader (Perkin-Elmer). For the ARE-bla assay, data were expressed as the ratio of the 460/530 
emission values, normalized to the positive control response (23 µM β-napthoflavone, 100%).  
For cytotoxicity, data were normalized to 100% for the negative control, (DMSO) and to 0% for 
the basal cytotoxic control (92 µM tetraoctyl ammonium bromide). 
 
Human Intestinal Epithelial Cells 
Nontransformed human intestinal cells, line FHs 74 Int, were purchased from American 
Tissue Culture Collection (Manassass, VA.) Cells were received at passage 12, and used until 
passage 17 or 18. Cells were maintained in Hybri-care 46X medium supplemented with 10% 
FBS, 1% antibiotic (10 units/mL penicillin G sodium, 10 µg/mL streptomycin sulfate, 25 µg/mL 
amphotericin B, 0.85% saline), and 30 ng/mL human epidermal growth factor at 37°C in a 
humidified atmosphere of 5% CO2. 
 
Cell Viability 
To reduce artifactual transcriptome alterations derived from cell death, monoHAA 
concentrations were selected that produced equal genomic DNA damage in FHs 74 Int cells with 
minimal effect on cell viability [27]. Cell viability was measured both immediately and 24 h after 
HAA exposure as previously reported [27]. 
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RNA Isolation, cDNA Synthesis, Real Time Quantitative PCR Analysis 
Four days prior to treatment 4×105 FHs 74 Int cells were seeded into the wells of a 6 well 
plate. Prior to exposure the cells were washed twice in Hank’s balanced salt solution (HBSS). 
HAAs were added in culture medium without FBS. After either 30 min or 4 h exposure, the cells 
were washed and harvested with trypsin (0.05%) and centrifuged. Four h was chosen as the time 
period for late expressing genes since this time was standardized for the DBPs to determine the 
equivalent levels of DNA damage [27, 30, 43]. For early gene expression, we chose 30 min 
treatments because this was the earliest interval that we could technically repeat the procedure 
and demonstrate consistent gene expression.  Aliquots of the cell suspension were retained for 
analyses of acute toxicity and genomic DNA damage with the single cell gel electrophoresis 
assay. After the supernatant was removed, RNA was isolated using a Qiagen RNeasy Mini Kit 
(Valencia, CA) following the manufacturers protocol. RNA integrity was determined using an 
Agilent 2100 Bioanalyzer (Santa Clara, CA). RNA integrity (RIN) numbers were determined for 
RNA from each exposure group and their concurrent negative controls. cDNA was prepared from 
RNA using SuperArray RT2 PCR Array First Strand Kit (SA Biosciences, Frederick, MD), cDNA 
samples were diluted in nuclease free water and stored at −20°C. Transcriptome profiles were 
analyzed using an Oxidative Stress and Antioxidant Defense pathway specific PCR array 
(SuperArray PAHs-065-24). A list of genes included in this PCR array is presented within their 
functional gene groupings (Table 3.4). Real-time PCR analysis was conducted using a two-step 
cycling program on a Stratagene Mx3000p thermocycler. Quality controls measuring genomic 
DNA contamination, reverse transcription, and PCR amplification efficiencies were included and 
 69 
 
analyzed. Because SYBR Green technology was utilized, melting curves were investigated for 
each gene analyzed. Wells with multiple amplification products were excluded.  
Safety and Data Handling 
Manipulations of toxic chemicals were conducted in certified biological/chemical stage-2 
safety hoods.  Average Ct values for each gene were calculated against the average of 5 
housekeeping genes (B2M, HPRT1, RPL13A, GAPDH and ACTB) using the SA Biosciences 
PCR analysis software RT2 Profiler Data Analysis Template. This software also estimated fold 
changes using the ΔΔCt method comparing treated cells to concurrent negative controls. The 
RankProd algorithm from the R Bioconductor package was used to test significance [44], with P 
≤ 0.05 considered significant.  The raw and normalized data are available in the Gene Expression 
Omnibus (GEO) database [45] under the NCBI tracking system GSE49698 series accession 
number. 
 
Results and Discussion 
ARE-dependent gene expression in a reporter gene assay demonstrated a strong response 
after cells were exposed to the monoHAAs. These responses implicated the generation of ROS as 
a function of monoHAA concentration. Previous studies suggested that the monoHAAs induced 
their cytotoxicity and genotoxicity by generating ROS based on the inhibition of GAPDH [36], 
the repression of  ATP levels, pyruvate remediation of cell stress and genotoxicity [37], 
repression of genotoxicity by radical scavengers and antioxidants [35, 46], and the direct 
measurement of cellular ROS after monoHAA treatment [46]. We proposed that each of the 
monoHAAs share a similar ROS-mediated mechanism of toxicity and tested this hypothesis 
using an ARE reporter assay and toxicogenomic analyses. 
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Toxicogenomics measured as toxicant-induced modulation of gene expression is a 
powerful analytical tool for cell stress. When compared to concurrent control transcriptome 
profiles, metabolic pathways involved in the cellular responses to toxic agents can be identified 
and provide insights into the biological mechanisms of toxicity. Many in vitro toxicogenomic 
studies employ human or mammalian tumor cell lines because of their ease of growth and in 
some cases cells are exposed to cytotoxic concentrations to observe effects on gene expression. 
Tumor cell lines inherently exhibit aberrant gene expression. With cytotoxic concentrations, 
transcript profiles will reflect those of dead or dying cells. We avoided these complications by 
using nontransformed human cells, concurrent negative controls at each treatment time and 
noncytotoxic concentrations of each monoHAA. An additional concern is that much of the gene 
expression literature is based on whole genome arrays without qRT-PCR confirmation. Our 
experimental design to determine transcriptome profiles of the monoHAAs was based on the 
direct use of PCR gene arrays. Our previous data argued that the monoHAAs were genotoxic due 
to their ability to induce ROS. This was the hypothesis that we tested using a ROS-responsive 
gene array.  
Besides the employment of a gene array for oxidative stress we used ARE transcription as 
an independent indicator. Briefly, the ARE-bla HepG2 cell line contains three stably integrated 
copies of the ARE derived from the human nicotinamide adenine dinucleotide phosphate 
(NADPH) quinone oxidoreductase 1 gene (NQO1) that drive the expression of a β-lactamase 
reporter gene [41]. Oxidative stress increases Nrf2 dependent and independent ARE-driven 
transcription of β-lactamase [41]. β-lactamase cleaves an exogenous substrate (coumarin) 
reducing the fluorescence resonance energy transfer (FRET) signal emitted by the intact 
substrate, while increasing the emission from the cleaved substrate. ARE-driven transcription of 
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β-lactamase is quantified by measuring the emission ratio of 460:530 nm, the emission of the β-
lactamase cleaved coumarin over the emission of the intact substrate.  Increased production of 
ARE-linked β-lactamase shifts the fluorescence towards 460 nm and is indicative of oxidative 
stress.  Each monoHAA generated concentration-dependent increases in ARE-dependent 
transcription of β-lactamase, as evidenced by the shift in fluorescence towards 460 nm; the data, 
normalized to the positive control (23 µM β-napthoflavone ) are displayed in Figure 3.1. These 
data demonstrated that the monoHAAs induced the activation of the antioxidant response 
pathway suggesting the generation of oxidative stress by these DBPs. The EC50 values of IAA, 
BAA or CAA that induced ARE-dependent β-lactamase activity were 1.17, 3.16 and 16.2 µM, 
respectively. Using the ECIR1.5 metric (i.e. a 1.5 fold increase over the baseline) [47] the values 
for IAA, BAA or CAA were 0.99, 1.96 and 8.65 µM, respectively. A Pearson Product Moment 
Correlation analysis demonstrated that ARE expression by the monoHAAs in human HepG2 
cells and genomic DNA damage induced by the monoHAAs in human FHs 74 Int cells [27] were 
highly correlated (r = 0.99; P ≤ 0.07). The response pattern of IAA > BAA >> CAA, observed in 
previous measurements of monoHAA-mediated toxicity, was conserved.  
ARE-dependent gene expression in a reporter gene assay demonstrated a strong response 
after cells were exposed to the monoHAAs implicating the generation of ROS as a function of 
monoHAA concentration.  These responses also indicated that transcription rates of genes 
regulated by ARE could be altered by monoHAA exposure. Transcription factors activated by 
oxidative stress can bind to AREs and modify transcription of genes coding for proteins with 
antioxidant or ROS detoxification functions. While a review of ARE responsive genes is beyond 
the scope of this paper, proteins acting in the glutathione/glutathione reductase (GSH/GSR), 
thioredoxin/thioredoxin reductase (Txn/Txnrd) pathways, as well as superoxide dismutases 
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(SOD), and catalase among others are all regulated by AREs [48]. The Human Oxidative Stress 
and Antioxidant Defense pathway specific PCR array contained members of each of these 
antioxidant pathways, along with additional genes involved with the production or metabolism of 
ROS and oxidative stress responsive genes. The oxidative stress responsive genes in the array 
were used collectively as an indicator of oxidative stress. Because it included several ARE-
responsive genes, this array served as an additional measure of the effect of monoHAAs on 
ARE-driven transcription. This analysis also allowed us to evaluate the effect of the monoHAAs 
on 83 specific genes and several pro-, or antioxidant pathways, at the transcriptional level. 
Toxicogenomic analysis quantifies mRNA and measures changes in transcription patterns 
in response to toxic insult. We exposed non-transformed human FHs 74 Int cells, to 22 µM IAA, 
57 µM BAA, or 3.42 mM CAA, concentrations that generated equivalent genomic genotoxicity 
(approximately 50% tail DNA values measured by single cell gel electrophoresis) without 
causing significant acute cytotoxicity [27]. This experimental design reduced artifactual changes 
due to transcriptome profiles generated from dead or dying cells, or from altered gene 
expression/regulation that might be associated with cancer cell lines. Two exposure times, 30 
min and 4 h, were chosen to evaluate early and late changes in transcription patterns. Each 
treatment was compared to a concurrent negative control. One gene, neutrophil cytosolic factor 1 
(NCF1), was removed from analysis because multiple amplification products, as evidenced by 
multiple peaks in the melting point analysis, were detected.  
Each of the monoHAAs altered transcription for multiple genes at both exposure times. 
Genes with statistically significant alterations in transcription (positive calls) are listed in Table 
3.1 (30 min exposure) and Table 3.2 (4 h exposure). Positive calls were sorted into functional 
gene groupings including: glutathione peroxidases (GPx), peroxiredoxins (TPx), other 
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peroxidases, other antioxidants, superoxide dismutases (SOD), other genes involved in 
superoxide metabolism, other genes involved in ROS metabolism, and oxidative stress 
responsive genes.  
After a 30 min exposure to individual monoHAAs, 31 of the 83 genes assayed exhibited 
significantly altered expression levels, as compared to negative controls, with a total of 45 
positive calls amongst all treated groups (Table 3.1, Figure 3.2). There was considerable overlap 
of altered gene expression, with 14 of the 31 (45.2%) positive calls generated by two 
monoHAAs. None of the altered gene expressions were shared by all 3 monoHAAs. Of the 45 
positive calls, 26 (57.8%) were downregulated and 19 (42.2%) were upregulated (Table 3.1).  
For the 4 h exposure, a total of 47 gene expression levels were altered amongst all 
treatment groups, with transcription levels of 28 genes significantly altered (Table 3.2, Figure 
3.2). Of the genes with significantly modified transcription levels, 11 (37.9%) were altered by 2 
monoHAAs, and 4 (13.8%) were altered by all three monoHAAs. Of the 47 positive calls, 26 
(55.3%) were downregulated and 21 (44.7%) were upregulated (Table 3.2).  
For each monoHAA exposure, at both time points, multiple oxidative stress responsive 
genes showed altered transcription patterns (Figures 3.2 and 3.3). Taking these genes collectively 
as an indicator, our hypothesis is supported that cells exposed to monoHAAs are responding to 
oxidative stress.  
Several genes involved in antioxidant defense or detoxification are regulated by the 
Nrf2/ARE system at the transcription level [48]. Analysis of the transcriptome profiles showed 
that ARE-responsive genes exhibited modified transcription levels after monoHAA challenge, 
although no clear pattern of regulation emerged when all ARE-responsive genes were 
considered. Some of the ARE-responsive genes were upregulated: epoxide hydrolase (EPHX2) 
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after 30 min exposure to BAA or CAA, sulfiredoxin (SRXN1) after 4 h exposures to IAA, BAA 
or CAA and thioredoxin reductase 1 (TXNRD1) after 4 h exposure to BAA or CAA. Other 
ARE-responsive genes were downregulated after 30 min: TXNRD1 with CAA, glutathione 
reductase (GSR) with IAA or BAA, as well as after 4 h: peroxiredoxin 3 (PRDX3) and GSR. 
ARE-regulated genes including SOD, and those peroxiredoxins and glutathione peroxidases not 
included in Tables 3.1 and 3.2 did not show altered transcription patterns after monoHAA 
exposures. These findings suggest that while monoHAAs activate ARE-driven transcription in 
the ARE-bla reporter system, the regulation of specific genes within the antioxidant pathways of 
the FHs cell line includes additional layers of complexity.   
Within the GSH/GSR pathway, GPX2, GPX6 and GSR genes were downregulated 
(Tables 3.1 and 3.2). None of the SOD genes or catalase displayed altered transcription after 
monoHAA exposures at either time point. These data along with the altered transcription of 
SRXN1 and TXNRD1 suggested that peroxiredoxins (Prx) were the main target for ROS 
generated during monoHAA challenge.  
Prx proteins reduce hydrogen peroxide, peroxynitrite, and lipid peroxides.  Each of the 6 
mammalian PRX genes was included in the gene array, however, only PRDX3 and PRDX4 were 
modified by monoHAA exposure. Peroxiredoxins contain 1 (Prx6) or 2 (Prx1-5) catalytic 
cysteine residue(s) that is/are oxidized during their peroxidase activity. TXNRD1 and SRXN1 
encode proteins capable of reducing oxidized Prxs. Txnrd1 acts indirectly by regenerating 
reduced Txn after it has been oxidized while reducing Prx [49]. Sulfiredoxin directly reduces 
Prx1-4, the so-called typical 2 cysteine Prx [50].  Both TXNRD1 and SRXN1 were upregulated 
by BAA and CAA or all monoHAAs, respectively, after 4 h. However, none of the PRX genes 
were upregulated at any time point. PRDX3, was downregulated after 4 h exposure to BAA and 
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IAA. The significance of the downregulation was unclear. However, post-transcriptional 
modifications that inactivate Prx provide localized increases in H2O2 concentration important for 
modifying signaling cascades. Prx3 specifically functions within the mitochondria to regulate 
apoptosis [51]. Prx proteins were modulated post-transcriptionally to allow local increases of 
H2O2 to modify growth factor signaling [52]. Metabolites of arachidonic acid (AA) metabolism 
oxidized and inhibited Prx1-3, suggesting a role in signaling pathways [53]. 
AA is liberated from membranes via calcium dependent cytosolic phospholipase A2 
(cPla2) and is metabolized through cyclooxygenase (COX) or lipoxygenase (LOX) pathways 
yielding eicosanoid signaling molecules [54]. Both COX [55] and LOX [56] pathways generate 
superoxide and lipid peroxides as byproducts of AA metabolism. Free AA was measured in the 
medium of IAA treated neurons [57]. PLA2 inhibitors [58], antioxidants [34] and the calcium 
chelator BAPTA-AM [34] each reduced IAA-mediated toxicity. These results suggest a process 
involving increased intracellular [Ca2+], activation of cPla2, and ROS production that is involved 
in IAA-generated neurotoxicity. In this study we found each monoHAA exposure altered mRNA 
levels of COX to a greater degree than LOX enzymes. ALOX12 mRNA was decreased after 
BAA (30 min and 4 h) or CAA (30 min) exposures. Conversely, PTGS2 (COX-2) was 
downregulated by BAA after 30 min but upregulated by IAA at 30 min, and upregulated by all 
three monoHAAs after 4 h exposures (Tables 3.1 and 3.2). COX-2 exhibited the largest increase 
in each of the 4 h treatment groups, with a >32× increase in BAA treated cells.  
In addition to the generation of ROS as a byproduct of AA metabolism, the upregulation 
of COX-2 suggests a possible inflammatory response which may impact human health.  Chen et 
al showed that CAA activated the stress associated mitogen activated protein kinase (MAPK) 
p38 pathway via oxidative stress [59]. Activated p38 phosphorylates and inactivates 
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tristetraproline preventing the degradation of both COX-2 and dual specific phosphatase 1 
(DUSP1) mRNA [60]. Our data demonstrated that 4 h exposures to BAA or IAA increased COX-
2 and DUSP1 mRNA levels, suggesting that activation of the p38 pathway may be a common 
response to monoHAA exposure. Cox-2 and p38 play critical roles in inflammation. Previous 
toxicogenomic analyses focused on DNA damage and repair pathways demonstrated that a 4 h 
exposure to IAA modified genes within the FcεRI receptor pathway [27]. FcεRI functions in 
phagocytosis and production of pro-inflammatory cytokines [61].  
Inflammation has been linked to all phases of cancer [62]. The link between COX-2 and 
bladder and colon cancers, the cancers most commonly associated with DBP exposures [7, 8], 
was well documented. Prostaglandin E2, a byproduct of COX-2 mediated AA metabolism, 
increased colon cancer growth by increasing β-catenin signaling [63]. Furthermore, COX-2 
inhibitors reduced growth of HT-29 and Caco-2 colon cancer cell lines [64], and inhibited 
haematogenous metastasis of colon cancer in mice [65]. COX-2 was detected in transitional cell 
carcinomas [66], and also squamous cell carcinomas [67] of the urinary bladder. Selective 
inhibitors of COX-2 reduced incidence of bladder cancer in male rats exposed to N-butyl-N-(4-
hydroxybutyl) nitrosamine [68, 69]. AA metabolism also inhibited the tumor suppressor PTEN 
[54]. Although further studies are needed to verify an inflammatory effect in vivo, the data 
presented here could have important implications in linking DBP exposure with associated 
adverse health outcomes. 
While previous studies showed ROS resulted from IAA exposures, the source(s) were not 
defined. Alterations in transcriptome profiles could provide insight into mechanisms by which 
ROS were generated during monoHAA exposure. Pro-oxidant encoding genes upregulated by 
two or more monoHAA exposures were considered potential sources of ROS. In addition to ROS 
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generated through COX-2 catalyzed metabolism of AA, two additional sources of ROS were 
identified in the hypohalous acid generating peroxidases (myeloperoxidase (MPO) and 
lactoperoxidase (LPO)) and  NADPH dependent oxidase 5 (NOX5) (Tables 3.1 and 3.2).  
MPO was upregulated by a 30 min exposure to BAA or CAA; LPO was upregulated by 
CAA or IAA (Table 3.1). NOX5 was upregulated by CAA after 30 min, and by each of the 
monoHAAs after 4 h exposure (Tables 3.1 and 3.2). Noxs generate superoxide anion (O2
−∙ ) by 
transferring an electron from NADPH to molecular oxygen. NOXs work in tandem with Lpo, or 
Mpo proteins in the epithelial mucosa [70] or phagocytes [71], respectively, to generate 
hypohalous acids (HOX, where X represents I, Br, Cl, or thiocyanate (SCN)) for host defense. 
Nox enzymes were activated by cPla2 [72], and Nox5 is Ca
2+
-dependent [73]. Additional 
research is needed to evaluate the source(s) of ROS generated during monoHAA exposure and 
their contributions to the overall oxidative imbalance. 
In summary, we employed the ARE-bla HepG2 reporter cell line as a biomarker for 
oxidative stress and observed an increase in ARE driven β-lactamase transcription in cells treated 
with each of the monoHAAs. Each exposure caused oxidative stress in the reporter cell line. The 
rank order IAA > BAA >> CAA found in the activation of the ARE response pathway is 
consistent with toxicological endpoints previously measured [27-29, 31, 32, 36, 37, 74]. 
Additionally we exposed non-transformed human embryonic intestinal epithelial cells (line FHs 
74 Int) to equally genotoxic, but non-cytotoxic levels of the monoHAAs, IAA, BAA, and CAA 
for 30 min or 4 h and investigated the transcription of 83 genes involved in oxidative stress and 
antioxidant response. Each monoHAA at both exposure times caused significant changes in 
transcriptome profiles. The high number of modified oxidative stress responsive genes confirmed 
previous reports that IAA and CAA induced oxidative stress, and demonstrated that BAA shared 
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this mechanism. The gene array data indicated a cellular response to oxidized Prx proteins, in 
that SRXN1 and TRXND1 were upregulated, whereas GSR was downregulated, and other 
antioxidant pathways were unchanged. The data also suggest a possible link between monoHAA 
exposure, inflammation, and cancer, with COX-2 connecting these three phenomena. The data 
indicated three possible sources of ROS, (1) HOX derived from peroxidase enzymes such as 
Mpo or Lpo, (2) O2
−∙ derived from Nox5, and (3) ROS derived from the metabolism of AA via 
COX-2. 
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Supporting Information 
MonoHAA Treatment for Toxicogenomic Analyses, RNA Isolation and Purification 
Four days prior to treatment, 4  105 FHs 74 Int cells were seeded in each well in six-well 
plates. FhS cells were treated with a 30 min or 4 h exposure to 22 µM IAA, 57 µM BAA or 3.42 
mM CAA. The distribution of genomic DNA damage for the negative control and for cells 
treated with IAA, BAA or CAA is presented in Figure 3.4. FHs cells were washed twice with 
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HBSS, harvested, and centrifuged at 300× g for 5 min. An aliquot of each cell suspension was 
retained prior to centrifugation for acute cytotoxicity and SCGE analyses. The supernatant was 
removed and RNA isolated using a Qiagen RNeasy Mini Kit. DNase treatment of the RNA 
samples was conducted using Ambion DNA-free DNase and the RNA concentrations were 
determined using the NanoDrop 1000 from Thermo Fisher Scientific. The resulting genomic 
DNA-free RNA was concentrated by vacuum centrifugation for 15 min using a Speedvac 
system. RNA quantity was determined using the Agilent 2100 Bioanalyzer. RNA Integrity 
Numbers (RIN) were in the range from 8.2 to 9.9 (RNA quality for microarray analysis must 
have RIN values greater than 7) [75]. High quality RNA is essential for qRT-PCR arrays. Figure 
3.5 presents the nanodrop, electrophoresis of the RNA isolated from the control and IAA-treated 
FHs cells. The capillary electrophoresis analysis of the RNA isolated from each FHs cell sample 
in the IAA experiments is illustrated in Figure 3.6. The RNA concentration and purity (RIN 
values) for each monoHAA treatment group is presented in Table 3.3. 
 
cDNA Synthesis 
cDNAs were synthesized using the SuperArray RT
2
 PCR Array First Strand Kit 
(Frederick, MD). RNA samples were diluted to a constant concentration for each monoHAA 
exposure. One µL of the P2 enzyme, from the SuperArray RT
2
 PCR Array First Strand Kit, was 
added to the nuclease-free PCR tube containing the diluted RNA. 
Using a MJ Research PTC-100 programmable thermocycler the annealing reaction was 
conducted at 70°C for 3 min and held on ice. The RT cocktail was prepared by mixing 10 µL of 
the annealing mixture with 10 µL of the RT cocktail. This mixture was incubated at 37°C for 60 
min and heated to 95°C for 5 min to hydrolyze the RNA and inactivate the reverse transcriptase. 
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The finished reaction was held on ice. After cDNA synthesis, the samples were diluted with 91 
µL of nuclease free water and stored at −20°C. 
 
qRT-PCR array  
An Oxidative Stress and Antioxidant Defense pathway specific PCR array (SuperArray 
PAHs-065-24) induced by the monoHAAs [76]. The human genes evaluated for their expression 
are listed in Table 3.4. An aliquot of the diluted first strand synthesis reaction was added to the 
SuperArray RT
2
 Real-Time SYBR Green/ROX PCR master mix and nuclease-free H2O. This 
cDNA/master mix cocktail was transferred to a sterile, nuclease free reservoir and 25 µL were 
placed into each well of a pathway specific qRT-PCR array. Optical cap strips were tightly 
placed onto each column and the microplate was centrifuged. Quantitative real-time PCR 
analysis was conducted using a two-step cycling program on a Stratagene Mx3000p 
thermocycler. For each array we analyzed quality controls that measured genomic DNA 
contamination, reverse transcription efficiency, and PCR amplification efficiencies and these 
quality control parameters were within accepted limits. 
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Tables and Figures 
 
Table 3.1. Gene Expression Level Changes vs. Concurrent Negative Controls after 30 min MonoHAA Exposure. 
  IAA BAA CAA 
Gene 
Symbol 
Functional Gene Group(s) Fold 
Change 
P-value Fold 
Change 
P-value Fold 
Change 
P-value 
ALOX12 Superoxide Metabolism   -2.286 0.015 -1.972 0.013 
APOE Antioxidant, Oxidative Stress Responsive -1.725 0.040     
CCL5 Oxidative Stress Responsive 3.588 0.001 2.424 0.004   
CYBA Superoxide Metabolism     -1.519 0.045 
CYGB Peroxidase, Oxidative Stress Responsive -1.941 0.038     
DGKK Oxidative Stress Responsive   2.057 0.008   
DHCR24 Oxidative Stress Responsive -1.832 0.050     
DUOX1 Peroxidase, Superoxide Metabolism, Oxidative Stress 
Responsive 
  -2.608 0.004 -2.334 0.001 
EPHX2 ROS Metabolism   2.856 0.001 8.041 < 0.001 
EPX Peroxidase, Oxidative Stress Responsive     -1.857 0.017 
GPX2 Glutathione Peroxidase, Oxidative Stress Responsive   -4.396 < 0.001   
GSR Antioxidant -4.521 <0.001 -3.433 0.007   
KRT1 Oxidative Stress Responsive     3.549 0.008 
LPO Peroxidase, Oxidative Stress Responsive 1.823 0.034   3.919 0.022 
MBL2 Oxidative Stress Responsive     2.702 0.038 
MPO Peroxidase, Oxidative Stress Responsive   1.516 0.035 2.509 0.004 
NOS2A Superoxide Metabolism     7.000 0.002 
NOX5 Superoxide Metabolism -1.782 0.042   3.901 0.004 
PIP3-E Peroxidase, Oxidative Stress Responsive 1.977 0.046 1.386 0.034   
PNKP Oxidative Stress Responsive -2.033 0.023   -1.701 0.011 
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Table 3.1. (cont.) 
PTGS2  
(COX-2) 
Peroxidase 5.122 < 0.001 -2.410 0.004   
PXDNL Peroxidase -3.182 0.012     
RNF7 Oxidative Stress Responsive 1.803 0.019     
SCARA3 Oxidative Stress Responsive     -1.840 0.013 
SFTPD ROS Metabolism     1.973 0.017 
SGK2 Oxidative Stress Responsive   -2.422 0.007   
SIRT2 Oxidative Stress Responsive -1.782 0.039   -1.616 0.017 
STK25 Oxidative Stress Responsive   -1.990 0.038   
TPO Peroxidase, Oxidative Stress Responsive   -2.339 0.012 -2.377 0.002 
TXNDC2 Antioxidant 3.775 0.001   -1.931 0.022 
TXNRD1 Antioxidant     -1.543 0.049 
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Table 3.2. Gene Expression Level Changes vs. Concurrent Negative Controls after 4 h MonoHAA Exposure. 
  IAA BAA CAA 
Gene 
Symbol 
Functional Gene Group(s) Fold 
Change 
P-value Fold 
Change 
P-value Fold 
Change 
P-value 
ALB Antioxidant 1.785 0.011     
ALOX12 Superoxide Metabolism   -3.125 0.020   
ANGPT7L Oxidative Stress Responsive   -5.900 0.001   
AOX1 ROS Metabolism 1.785 0.017     
CCL5 Oxidative Stress Responsive 1.981 0.011   -2.074 0.018 
DUOX1 Peroxidase, Superoxide Metabolism, Oxidative Stress Responsive -11.610 < 0.001 -2.463 0.044   
DUSP1 Oxidative Stress Responsive 1.994 0.009 14.117 < 0.001   
EPHX2 ROS Metabolism     -2.737 0.004 
EPX Peroxidase, Oxidative Stress Responsive -2.331 0.034 -3.993 0.004 -1.810 0.021 
GLRX2 Oxidative Stress Responsive   -4.837 0.006   
GPR156 Peroxidase, Oxidative Stress Responsive   -2.504 0.032   
GPX2 Glutathione Peroxidase, Oxidative Stress Responsive   -2.957 0.019   
GPX6 Glutathione Peroxidase, Oxidative Stress Responsive     -2.377 0.016 
GSR Antioxidant -2.683 0.012 -2.671 0.037   
MTL5 Oxidative Stress Responsive 1.949 0.006     
NOS2A Superoxide Metabolism -4.020 0.002   -1.931 0.041 
NOX5 Superoxide Metabolism 1.976 0.008 2.323 0.016 3.830 0.001 
PIP3-E Peroxidase, Oxidative Stress Responsive -4.058 0.003   4.694 0.000 
PRDX3 Peroxiredoxins   -3.040 0.014 -1.823 0.040 
PRDX4 Peroxiredoxins     -1.985 0.032 
PTGS2 
(COX-2) 
Peroxidase 5.108 < 0.001 32.282 < 0.001 8.153 0.000 
PXDNL Peroxidase -3.326 0.009   1.845 0.045 
SFTPD ROS Metabolism   -3.476 0.009   
SGK2 Oxidative Stress Responsive 1.433 0.033 3.587 0.007   
SRXN1 Antioxidant, Oxidative Stress Responsive 2.366 0.002 4.477 0.001 2.320 0.007 
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Table 3.2. (cont.) 
TPO Peroxidase, Oxidative Stress Responsive   -3.866 0.004   
TTN Peroxidase, Oxidative Stress Responsive -3.665 0.003 -5.467 0.001   
TXNRD1 Antioxidant   1.918 0.036 2.341 0.008 
 
 
 93 
 
 
 
 
 
 
 
 
Table 3.3. RNA concentration and purity for each monoHAA treatment group 
monoHAA Treatment 
Group 
RNA Concentration 
Range (ng/µL) 
RNA Integrity Number 
30 min Control (IAA) 109 – 146 9.4 – 9.9 
30 min IAA 214 – 287 9.7 – 9.9 
4 h Control (IAA) 66 – 161 8.2 – 9.7 
4 h IAA 190 – 214 9.7 – 9.8 
30 min Control (BAA) 215 – 230 9.9 – 10.0 
30 min BAA 280 – 343 9.9 – 10.0 
4 h Control (BAA) 43 – 68 9.4 – 9.6 
4 h BAA 28 – 259 8.4 – 9.9 
30 min Control (CAA) 117 – 185 9.9 – 10.0 
30 min CAA 138 – 235 9.8 – 10.0 
4 h Control (CAA) 120 – 206 9.8 – 10.0 
4 h CAA 94 – 232 9.8 – 10.0 
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Table 3.4. SABiosciences Human Oxidative Stress and Antioxidant Defense RT2 Profiler PCR 
Array PAHS-065A 
Description Gene 
Symbol 
Functional Gene Group(s) 
Albumin ALB Antioxidant 
Arachidonate 12-lipoxygenase ALOX12 Superoxide Metabolism 
Angiopoietin-like 7 ANGPT7L Oxidative Stress Repsonsive 
Aldehyde oxidase 1 AOX1 ROS Metabolism 
Apolipoprotein E APOE Antioxidant, Oxidative Stress 
Responsive 
ATX1 antioxidant protein 1 homolog 
(yeast) 
ATOX1 Oxidative Stress Responsive 
BCL2/adenovirus E1B 19kDa 
interacting protein 3 
BNIP3 ROS Metabolism 
Catalase CAT Peroxidase, Oxidative Stress 
Responsive 
Chemokine (C-C motif) ligand 5 CCL5 Oxidative Stress Responsive 
Copper chaperone for superoxide 
dismutase 
CCS Superoxide Metabolism 
Cold shock domain containing E1, 
RNA-binding 
CSDE1 Peroxidase, Oxidative Stress 
Responsive 
Cytochrome b-245, alpha polypeptide CYBA Superoxide Metabolism 
Cytoglobin CYGB Peroxidase, Oxidative Stress 
Responsive 
Diacylglycerol kinase, kappa DGKK Oxidative Stress Responsive 
24-dehydrocholesterol reductase DHCR24 Oxidative Stress Responsive 
Dual oxidase 1 DUOX1 Peroxidase, Superoxide 
Metabolism, Oxidative Stress 
Responsive 
Dual oxidase 2 DUOX2 Peroxidase, Oxidative Stress 
Responsive 
Dual specificity phosphatase 1 DUSP1 Oxidative Stress Repsonsive 
Epoxide hydrolase 2, cytoplasmic EPHX2 ROS Metabolism 
Eosinophil peroxidase EPX Peroxidase, Oxidative Stress 
Responsive 
Forkhead box M1 FOXM1 Oxidative Stress Responsive 
General transcription factor II,i GTF2I Superoxide Metabolism 
Glutaredoxin 2 GLRX2 Oxidative Stress Repsonsive 
G protein-coupled receptor 156 GPR156 Peroxidase, Oxidative Stress 
Responsive 
Glutathione peroxidase 1 GPX1 Glutathione Peroxidase, Oxidative 
Stress Responsive 
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Table 3.4. (cont.) 
 
Glutathione peroxidease 2 
(gastrointestinal) 
GPX2 Glutathione Peroxidase, Oxidative 
Stress Responsive 
Glutathione peroxidase 3 (plasma) GPX3 Glutathione Peroxidase, Oxidative 
Stress Responsive 
Glutathione peroxidase 4 
(phospholipid hydroperoxidase) 
GPX4 Glutathione Peroxidase, Oxidative 
Stress Responsive 
Glutathione peroxidase 5 (epididymal 
androgen-related protein) 
GPX5 Glutathione Peroxidase, Oxidative 
Stress Responsive 
Glutathione peroxidase 6 (olfactory) GPX6 Glutathione Peroxidase, Oxidative 
Stress Responsive 
Glutathione peroxidase 7  GPX7 Glutathione Peroxidase, Oxidative 
Stress Responsive 
Glutathione reductase GSR Antioxidant 
Glutathione synthetase GSS Oxidative Stress Responsive 
Glutathione transferase zeta 1 
(maleylacetocetate isomerase) 
GSTZ1 Glutatathione Peroxidase 
Keratin 1 KRT1 Oxidative Stress Responsive 
Lactoperoxidase LPO Peroxidase, Oxidative Stress 
Responsive 
Mannose-binding lectin (protein C) 2, 
soluble (opsonic defect) 
MBL2 Oxidative Stress Responsive 
Microsomal glutathione S-transferase 
3 
MGST3 Peroxidase 
Myeloperoxidase MPO Peroxidase, Oxidative Stress 
Responsive 
MpV17 mitochondrial inner 
membrane protein 
MPV17 ROS Metabolism 
Methionine sulfoxide reductase A MSRA Oxidative Stress Responsive 
Metallothionein 3 MT3 Antioxidant, Superoxide 
Metabolism 
Metallothionein-like 5, testis-specific 
(tesmin) 
MTL5 Oxidative Stress Repsonsive 
Neutrophil cytosolic factor 1, (chronic 
granulomatous disease, autosomal 1) 
NCF1 Superoxide Metabolism 
Neutrophil cytosolic factor 2, (65kDa, 
chronic granulomatous disease, 
autosomal 2) 
NCF2 Superoxide Metabolism 
Non-metastatic cells 5, protein 
expressed in (nucleoside-diphosphate 
kinase) 
NME5 Oxidative Stress Responsive 
Nitric oxide synthase 2A, inducible NOS2A Superoxide Metabolism 
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Table 3.4. (cont.) 
 
NADPH oxidase, EF-hand calcium 
binding domain 5 
NOX5 Superoxide Metabolism 
Nudix (nucleoside diphosphate linked 
moiety X)-type motif 1 
NUDT1 Oxidative Stress Responsive 
Oxidation resistance 1 OXR1 Oxidative Stress Responsive 
Oxidative-stress responsive 1 OXSR1 Oxidative Stress Responsive 
PDZ and LIM domain 1 (elfin) PDLIM1 Oxidative Stress Responsive 
Phosphoinositide-binding protein 
PIP3-E 
PIP3-E Peroxidase, Oxidative Stress 
Responsive 
Polynucleotide kinase 3'-phosphatase PNKP Oxidative Stress Responsive 
Peroxiredoxin 1 PRDX1 Peroxiredoxin 
Peroxiredoxin 2 PRDX2 Peroxiredoxin, Oxidative Stress 
Responsive 
Peroxiredoxin 3 PRDX3 Peroxiredoxin 
Peroxiredoxin 4 PRDX4 Peroxiredoxin 
Peroxiredoxin 5 PRDX5 Peroxiredoxin, Oxidative Stress 
Responsive 
Peroxiredoxin 6 PRDX6 Peroxiredoxin, Oxidative Stress 
Responsive 
Phophatidylinositol, 3,4,5-
triphosphate-dependent RAC 
exchanger 1 
PREX1 Superoxide Metabolism 
Proteoglycan 3 PRG3 Superoxide Metabolism 
Prion protein (p27-30) (Creeutzfeldt-
Jakob disease, Gerstmann-Strausler-
Scheinker syndrome, fatal familial 
insomnia) 
PRNP Oxidative Stress Responsive 
Prostaglandin-endoperoxide synthase 
1 (prostaglandin G/H synthase and 
cyclooxygenase) 
PTGS1 Peroxidase 
Prostaglandin-endoperoxide synthase 
2 (prostaglandin G/H synthase and 
cyclooxygenase) 
PTGS2 Peroxidase 
Peroxidasin homolog (Drosophila) PXDN Peroxidase 
Peroxidasin homolog (Drosophila)-like PXDNL Peroxidase 
Ring finger protein 7 RNF7 Oxidative Stress Responsive 
Scavenger receptor class A, member 3 SCARA3 Oxidative Stress Responsive 
Selenoprotein S SELS Antioxidant, Oxidative Stress 
Responsive 
Selenoprotein P, plasma, 1 SEPP1 Oxidative Stress Responsive 
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Table 3.4. (cont.) 
 
Surfactant protein D SFTPD ROS Metabolism 
Serum/glucocorticoid regulated 
kinase 2 
SGK2 Oxidative Stress Responsive 
Sirtuin (silent mating type information 
regulation 2 homolog) 2 (S. cerevisiae) 
SIRT2 Oxidative Stress Responsive 
Superoxide dismutase 1, soluble 
(amytrophic lateral sclerosis 1 (adult)) 
SOD1 Antioxidant, Superoxide 
Dismutase, Oxidative Stress 
Responsive 
Superoxide dismutase 2, 
mitochondrial 
SOD2 Superoxide Dismutase, Oxidative 
Stress Responsive 
Superoxide dismutase 3, extracellular SOD3 Antioxidant, Superoxide Dismutase 
Sulfiredoxin 1 homolog (S. cerevisiae) SRXN1 Antioxidant, Oxidative Stress 
Responsive 
Serine/threonine kinase 25 (STE20 
homolog, yeast) 
STK25 Oxidative Stress Responsive 
Thyroid peroxidase TPO Peroxidase, Oxidative Stress 
Responsive 
Titin TTN Peroxidase, Oxidative Stress 
Responsive 
Thioredoxin domain containing 2 
(spermatozoa) 
TXNDC2 Antioxidant 
Thioredoxin reductase 1 TXNRD1 Antioxidant 
Thioredoxin reductase 2 TXNRD2 Antioxidant, Oxidative Stress 
Responsive 
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Figure 3.1. Concentration-response curves for IAA, BAA and CAA for the induced expression of 
the ARE-controlled β-lactamase reporter gene in ARE-bla HepG2 cells. The data are presented 
as the mean percent activity (±SE) of the positive control (23 µM β-napthoflavone). 
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         Figure 3.2. The number of ROS-responding genes listed by functional groups that exhibited altered expression after 30 min        
or 4 h exposure to 22 µM IAA, 57 µM BAA, or 3.4 mM CAA. Some genes were counted more than once because of their 
involvement in multiple pathways. 
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Figure 3.3. The number of oxidative stress responsive genes listed by functional groups illustrating upregulation or downregulation 
after 30 min or 4 h exposure to 22 µM IAA, 57 µM BAA, or 3.4 mM CAA. Some genes were counted more than once because of their 
involvement in multiple pathways. 
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Figure 3.4. Histograms of the distribution of SCGE genomic DNA damage in human FHs 
cells for the negative control, and for cells that expressed an average value of 50 %Tail 
DNA for BAA, CAA and IAA-induced genotoxic damage. 
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Figure 3.5. Electrophoresis of RNA samples isolated from control and FHs cells 
treated with IAA. 
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Figure 3.6. Capillary electrophoresis of RNA isolated from concurrent negative controls and 
IAA-treated human FHs cells. Note RIN values for RNA quality exceed the minimum value of 
7.0. 
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CHAPTER 4: CALCIUM AND REACTIVE OXYGEN SPECIES IN DBP INDUCED 
GENOTOXICITY:  IS THERE A CUMULATIVE EFFECT? 
 
Introduction 
Disinfection of drinking water greatly improved public health by reducing diseases 
transmitted through drinking water [1]. Chemical disinfectants, such as chlorine, chloramines, or 
ozone kill pathogenic microorganisms otherwise present in drinking water, but also react with 
organic and inorganic materials forming toxic disinfection byproducts (DBPs) as an unintended 
consequence. Since they were first discovered in 1974 [2, 3] over 600 individual DBPs have 
been discovered in disinfected water, where they are generated at relatively low (ranging from 
low µg/L to ng/L) concentrations [4]. 
 Long term exposure to DBPs was associated with small but significant increased risks 
for colorectal [5] and bladder cancers [6]; exposure to DBPs prior to and during gestation was 
also associated with increased risk for adverse pregnancy outcomes [7]. Individual DBPs were 
genotoxic, mutagenic, carcinogenic, and teratogenic (reviewed in [8]). However, the toxicity of 
these DBPs individually cannot account for the increased risk of cancer measured in the 
epidemiology because they did not cause bladder or colon cancers and the carcinogenic 
concentrations in laboratory animals would not be achieved by drinking, bathing, and/or 
swimming in disinfected water [9].  
Although the link between DBP exposure to cancer and adverse pregnancy outcomes are 
not known, oxidative stress and genotoxicity were suggested as possible mechanisms [10]. In a 
systematic evaluation of DBP toxicity in a Chinese hamster ovary (CHO) model cell line 
monohalogenated haloacetic acids (monoHAAs) [11], acetonitriles (monoHANs) [12], and 
acetamides (monoHAMs) [13] were among the most genotoxic. Members of each of these 
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classes generated biomarkers of oxidative stress [14-16]. Buffering intracellular calcium (Ca
2+
) 
with EGTA-AM [15]  or BAPTA-AM [17] reduced toxicity generated by iodoacetamide (IAM) 
and iodoacetate (IOA), respectively, and also reduced the generation of reactive oxygen species 
(ROS) in iodoacetate treated neurons [18]. While IOA (and presumably iodoacetic acid) and 
IAM shared increased intracellular Ca
2+
 and the generation of ROS in their respective toxic 
cascades, different mechanisms have been proposed for initiating their toxicities. IAA is a potent 
inhibitor of the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and its 
toxicity is thought to be derived from this inhibition [19]; the ability to inhibit GAPDH strongly 
correlated with multiple toxicological endpoints for each of the monoHAAs, which suggested 
inhibition of GAPDH was shared as a mechanism among these compounds [20]. IAM is a 
weaker inhibitor of GAPDH, but reacts more readily with glutathione (GSH) and depletion of 
this important intracellular antioxidant and electrophile scavenging tripeptide is likely initiating 
the toxic cascade associated with this compound [19]. The monoHANs are structurally similar to 
both the monoHAAs and monoHAMS and reacted with GSH [21]. 
14
C labeled chloroacetonitrile 
(CAN) was detected in DNA; however, this reactivity was dependent on GSH depletion [22]. 
Induction of oxidative stress was an important initiator of toxicity for CAN under physiological 
GSH concentrations [14, 23]. 
The purpose of this research was to first investigate the roles ROS and intracellular Ca
2+
 
play in the genotoxicity induced by the monoHAAs. We then extended this research to include 
bromoacetamide (BAM), and bromoacetonitrile (BAN) so as to determine if multiple chemical 
classes generated in disinfected waters might converge at these steps in a cumulative toxic 
cascade.  
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  Evaluating the toxicity of DBP mixtures will provide needed information linking DBP 
exposures to the adverse health outcomes measured in epidemiologic studies. In a series of 
studies Dawson et al evaluated interactions of binary mixtures of SN2 reactive electrophiles using 
a cytotoxicity endpoint [21, 24, 25]. Within the monoHANs, iodoacetonitrile, BAN, and CAN 
showed additive toxicity, which, the authors suggested, indicated a single shared mechanism 
[21]. Ethyl bromoacetate, and ethyl iodoacetate also showed additive toxicity [24] as did the 
mixture of these compounds with the monoHANs [25], suggesting that members of these two 
chemical classes interact to generate toxicity. To gain a better understanding of the cumulative 
effect of multiple DBP classes on genotoxicity we used SCGE to evaluate DNA damage induced 
by defined component mixtures of bromoacetic acid (BAA), BAN, and BAM, three structurally 
related, SN2 reactive, electophilic chemicals that generate oxidative stress through different 
mechanisms.  
 
Materials and Methods 
Chemicals and Reagents 
General reagents were purchased from Fisher Scientific Co. (Itasca, IL) or Aldrich 
Chemical Co. (St. Louis, MO). Bromoacetic acid and chloroacetic acid were purchased from 
Fluka Chemical Co. (Buchs, Switzerland). Iodoacetic acid, bromoacetonitrile (97%,), butylated 
hydroxianisole (BHA), N-acetyl L-cysteine (NAC) and 1,2- bis(2-aminophenoxy)ethane-
N,N,N’,N’-tetraacetic acid tetrakis (acetoxymethyl ester)( BAPTA-AM) were purchased from 
Sigma-Aldrich (St. Louis, MO). Cell culture medium (Hamm’s F12) and fetal bovine serum 
(FBS) were purchased from Fisher Scientific Co. Stock solutions of IAA, BAA, CAA, BAN, 
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BAM, BHA (1 M) and ) BAPTA-AM (50 mM) were prepared in DMSO and stored in sterile 
glass vials at -22 °C. Stock solutions were diluted in F12 medium immediately prior to use.    
 
Cell Culture 
Chinese hamster ovary (CHO) cell line AS52 were maintained in Hamm’s F12 medium 
supplemented with 5% fetal bovine serum (FBS) at 37 °C in a 5% CO2 atmosphere. Cells were 
grown on 100 mm glass tissue culture plates.   
 
Single Cell Gel Electrophoresis 
Single cell gel electrophoresis was used to measure genomic DNA damage in response to 
various agents. Minor modifications to the detailed procedure previously published [26] were 
used.  Briefly, 4 × 10
5
 CHO cells in Hamm’s F12 medium supplemented with 5 % FBS were 
added to each well of a 96 well microtiter plate. The cells were incubated overnight in a 
humidified 5% CO2 atmosphere at 37 °C. Immediately prior to DBP exposure, the medium was 
aspirated and cells were washed twice with 100 µL of Hank’s balanced salt solution (HBSS). 
Cells were treated with DBP in 25 µL of F12 medium (without serum) for 4 h at 37 °C and 5% 
CO2.  Wells were covered with sterile Alumnaseal ™ during treatment. After the exposure 
period medium was aspirated, cells were washed twice with HBSS and harvested with 50 µL 
trypsin (0.005% in HBSS). 70 µL of F12 + 5% FBS was added to inactivate the trypsin. After a 
10 µL aliquot of cell suspension was reserved for acute cytotoxicity evaluation, the remainder 
was mixed with 120 µL 1% low melting point agarose (LMA) prepared in phosphate buffered 
saline. 90 µL of the agarose cell suspension was pipetted onto a microscope slide previous 
covered with 1% normal melting point agarose (prepared in deionized water); a cover slip was 
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added to distribute the agarose suspension. An additional layer of LMA (0.5%) was added after 
the initial layer solidified. The gels were submerged overnight in lysing solution (2.5 M NaCl, 
100 mM Na2 EDTA, 10 mM Tris, 1% sodium sarcosinate, 1% Triton X-100, and 10% DMSO) 
at 4 °C. The DNA was denatured in alkaline electrophoresis buffer (300 mM NaOH, 1mM 
EDTA) for 20 minutes and then electrophoresed at 72 V/cm (25 V, 300 mA) for 40 min at 4 °C.  
After electrophoresis the slides were removed from electrophoresis buffer and neutralized with 
700 mM Tris buffer pH 7.5. The slides were rinsed in cold deionized water, dehydrated in 
methanol for 20 min at 4 °C and then dried for 10 min in a 50 °C oven. The gels were rehydrated 
in 4 °C deionized water for 30 min and stained with ethidium bromide (60 µg/mL) for 5 min. 
DNA damage was quantified as mean % tail DNA under a Zeiss fluorescence microscope using 
the Comet IV imaging system (Perspective Instruments, Suffolk UK).  
Acute toxicity for treated and control cells was evaluated with the Trypan blue (0.05% in 
phosphate buffered saline) vital dye exclusion assay. Cell viability was ≥ 90% for all 
experiments (data not shown). 
 
The Effect of BHA on MonoHAA Induced DNA Damage 
To measure the effect of the antioxidant butylated hydroxianisole (BHA), cells were 
exposed to IAA (15 μM), BAA (30 μM) or CAA (5 mM), concentrations chosen to induce a 
similar amount of genomic DNA damage. In addition to mono-HAA some of the cells were co-
treated with BHA (100, 250, or 500 μM). DNA damage was measured using the SCGE assay 
described previously, and a concentration response relationship for the BHA mediated effect on 
monoHAA induced DNA damage was evaluated by comparing positive control cells (monoHAA 
alone) to monoHAA + BHA co-treated cells. Positive control % tail DNA values were set to 
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100% and the monoHAA + BHA data were normalized to, and reported as a percentage of their 
respective positive controls.  
 
The Effect of BAPTA-AM on DBP Induced DNA Damage 
To measure the effect of the specific intracellular calcium chelator, BAPTA-AM on 
genotoxicity of individual DBPs, CHO cells were exposed to IAA (25 μM), BAA (75 μM), CAA 
(5 mM), BAN (60 µM) or BAM (60 µM), the genomic DNA damage induced by DBP alone 
served as the positive control value (100%) for each compound. BAPTA-AM (100 µM or 200 
μM) was co-treated with each of the monoHAAs, BAN, or BAM to measure the effect of 
intracellular Ca
2+
 chelation on genomic DNA damage induced by each of the DBPs. The mean 
SCGE % tail DNA was calculated for each BAPTA-AM concentration. The positive control 
values were set to 100%; data for DBP + BAPTA-AM were reported as the % of their respective 
positive control. Ethylmethanesulfonate (EMS) (3.8 mM) and hydrogen peroxide (H2O2) 
(0.003% v/v) served as additional non-specific DNA damage controls. 
 
The Effect of NAC on Monobrominated DBP Induced DNA Damage 
To investigate a possible role of GSH depletion in the induction of genomic DNA 
damage by BAN, BAM, and BAA, the protective effect of the GSH precursor, NAC, was 
measured. CHO cells were treated with BAA (250 µM), BAN (60 µM) or BAM (60 µM) in the 
absence and presence of NAC (100 µM, 250 µM, or 500 µM). DNA damage was measured 
using the SCGE assay described previously. CHO cells treated with DBP alone served as a 
positive control; positive control SCGE % tail DNA values were set to 100% and the DBP + 
NAC treated cell % tail DNA data were normalized to their respective positive controls.  
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Genotoxicity of Monobrominated DBP Mixtures 
To investigate the interaction of binary mixtures of BAA, BAN, and BAM, CHO cells 
were treated with a low concentration (30 µM BAN and BAM, or 125 µM BAA) a high 
concentration (60 µM BAN and BAM, or 250 µM BAA), and a mixture of the low 
concentrations. Genomic DNA damage was measured using SCGE methods described above. 
DNA damage for the mixtures was compared to DNA damage induced by individual DBPS.  
 
Statistical Analyses 
For DNA damage the unit of measure for each microgel was the average % tail DNA, 
which is the amount of DNA that migrated into the gel from the nucleus. The mean % tail DNA 
values were calculated for the microgels in a treatment group and were analyzed with an 
ANOVA statistical test. If a significant F value of P < 0.05 was obtained, a Holm-Sidak pairwise 
comparison versus the control group analysis was conducted (power ≥ 0.8 at α = 0.05). 
 
Results and Discussion 
Calcium and Reactive Oxygen Species in MonoHAA Induced Genotoxicity 
 The monoHAAs were genotoxic in CHO cells [26, 27], but did not induce damage in 
acellular DNA [20]. IAA inhibited the glycolytic enzyme GAPDH and generated a neurotoxic 
cascade that included disruption of intracellular calcium homeostasis (increased intracellular 
Ca
2+
 concentration ([Ca
2+
]i)) and the generation of ROS [18]. ROS can damage DNA directly or 
indirectly by generating byproducts of lipid peroxidation, such as malondialdehyde and 4-
hydroxynonenal, which are genotoxic [28]. Therefore, generation of ROS subsequent to IAA 
exposure was investigated as a possible mechanism for genotoxicity; the antioxidants BHA and 
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catalase reduced genomic DNA damage in CHO cells exposed to IAA [29]. Each of the 
monoHAAs inhibited GAPDH activity [20] and generated biomarkers of oxidative stress [16], 
indicating they shared a similar mode of toxic action.  Here we investigated the involvement of 
ROS and Ca
2+
 in monoHAA induced genomic DNA damage.   
 As previously reported [26, 27], each of the monoHAAs induced genomic DNA damage 
in CHO AS52 cells (Figure 4.1 and 4.2). Concentrations of monoHAAs that generated 
approximately similar SCGE % tail DNA values were chosen for further analysis. IAA (15 µM), 
BAA (30 µM), and CAA (5 mM) alone served as positive control values. Co-treating the cells 
with BHA 250 µM and 500 µM BHA significantly (P ≤ 0.001 for IAA vs. IAA + 250 µM, IAA 
vs. IAA + 500 µm BHA, BAA vs. BAA + 500 µM BHA and CAA vs. CAA + 500 µM BHA; P 
≤ 0.020 for BAA vs. BAA + 250 µM BHA; and P ≤ 0.008 for CAA vs. CAA 250 µM BHA) 
reduced the amount of damage that accumulated in the nuclei during monoHAA exposures 
(Figure 4.1). A BHA concentration dependent reduction of monoHAA induced genomic DNA 
damage was observed (Figure 4.1), however, at the highest BHA concentration tested (500 µM), 
a significant amount of DNA (62.8%, 42.9 %, and 81.5% for IAA, BAA, and CAA respectively) 
migrated into the tail under the electrophoretic force. The antioxidants vitamin E (α-tocopherol) 
and nordihydroguaiaretic acid (NDGA) offered more substantial protection against iodoacetate 
induced neurotoxicity [18], but in general our data supported the hypothesis that monoHAA 
derived genotoxicity is dependent on the generation of ROS.  
Co-treating the cells with the calcium specific intracellular chelator, BAPTA-AM, also 
significantly reduced the genotoxicity induced by IAA (30 µM), BAA (75 µM), and CAA (5 
mM) (Figure 4.2). BAPTA-AM at 100 µM produced a significant (P ≤ 0.001) reduction of % tail 
DNA compared to positive controls for IAA and CAA. Buffering [Ca
2+
]i with 200 µM BAPTA-
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AM reduced DNA damage induced by each of the monoHAAs by > 75% (Figure 4.2). To assure 
the effect of BAPTA-AM on monoHAA-induced genotoxicity was not artifactual, its effect on 
two additional DNA damaging agents was evaluated. BAPTA-AM (200 µM) provided a small 
(<10%) but significant (P ≤ 0.001) protective effect when compared to EMS alone (Figure 4.3). 
BAPTA-AM (200 µM) reduced DNA damage induced by H2O2 by ~ 20% (P ≤ 0.001) (Figure 
4.3). Compared to the EMS and H2O2 controls BAPTA-AM had a much greater effect on 
monoHAA induced genotoxicity (Figure 4.2) these data eliminated concerns of a non-specific 
protective effect. 
The monoHAA + BAPTA-AM data indicate that elevated [Ca
2+
]i  played a critical role in 
monoHAA induced genotoxicity. Buffering cytosolic Ca
2+
 in hippocampal neurons effectively 
reduced ROS generated after IAA exposure [18]. Taken with the ability of antioxidants to reduce 
monoHAA induced genomic DNA damage shown here (Figure 1.1) and previously [29], these 
data suggest that elevated [Ca
2+
]i  is involved in the generation of ROS that damage DNA.  
Glycolysis is closely linked with maintaining Ca
2+
 homeostasis, especially within the 
endoplasmic/sarcoplasmic reticulum (ER/SR). Glycolytic enzymes were found associated on the 
SR membrane where they could produce a local ATP concentration used to fuel the SR/ER Ca
2+
 
ATPase (SERCA), which pumps Ca
2+
 down its chemical gradient into the ER/SR; IAA inhibited 
SERCA activity indirectly as exogenous ATP restored Ca
2+
 influx into the SR [30]. Glycolytic 
inhibitors, including IAA depleted intracellular Ca
2+
 stores in hippocampal neurons much more 
efficiently than mitochondrial inhibitors further implicated local ATP production maintaining 
Ca
2+
 homeostasis [31]. Toxicological studies using the irreversible SERCA inhibitor 
thapsigargin showed that disrupting SERCA function is sufficient to generate ROS, peroxidation 
of the ER membrane, and ER stress [32, 33].  
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Calcium and GSH in BAN, BAM, and BAA Induced Toxicity 
Disruption of Ca
2+
 homeostasis was also implicated in IAM toxicity, as EGTA-AM, an 
intracellular Ca
2+
 chelator, reduced cytotoxicity induced by this chemical [15]. The cytotoxic 
mode of action proposed for IAM includes depletion of GSH, protein aggregation via 
intermolecular disulfide bonding, disruption of ER Ca
2+ 
homeostasis and generation of ROS 
[34]. CAN depleted GSH and induced oxidative stress in mouse embryos in vivo [23]. Because 
monoHAAs, monoHANs, and monoHAMs are all present in disinfected water, it is important to 
investigate how these toxicants might interact. We wanted to determine if increased [Ca
2+
]i was 
contributing to genotoxicity induced by the monoHANs and monoHAMs. It was determined 
through investigating binary mixtures that each of the monoHANs act through a common 
mechanism [21], thus we selected the brominated species, BAN and BAM, as models for further 
investigation and compared these with BAA.  
As previously demonstrated [12, 13], both BAN (60 µM), and BAM (60 µM) generated 
significant genomic DNA damage in CHO cells (Figure 4.4). BAPTA-AM reduced BAN and 
BAM genotoxicity in a concentration dependent manner (Figure 4.4). The highest BAPTA-AM 
concentration (200 µM) significantly (P ≤ 0.001) reduced BAN and BAM induced DNA damage 
by 63.9% and 73.6% relative to the positive controls, respectively. BAPTA-AM’s effect on BAN 
and BAM induced genotoxicity was comparable to the 76.0% reduction of BAA induced DNA 
damage (Figure 4.4). 
Based on the data presented in Figure 4.4, each of BAN, BAM, and BAA required 
increased [Ca
2+
]i  to reach their maximum genotoxic potency. However, different mechanisms of 
intracellular Ca
2+
 homeostasis disruption have been proposed, with GSH depletion for BAN and 
BAM, and GAPDH inhibition being the initiating event proposed for BAA. To further 
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investigate the role GSH plays in the toxicity of these compounds exogenous NAC, a GSH 
precursor, was co-treated with BAN, BAM, and BAA. Genotoxic concentrations of each 
compound (60 µM BAN and BAM, and 250 µM BAA) served as positive controls; NAC was 
supplemented at 100 µM, 250 µM, and 500 µM and % tail DNA values for co-treated cells are 
reported as % of their respective positive controls (Figure 4.5). For BAN and BAM a clear NAC 
concentration dependent reduction of DNA damage is evident (Figure 4.5); significant (P ≤ 
0.001) reductions of DNA damage occurred at 100 µM NAC and 250 µM NAC for BAN and 
BAM, respectively. NAC did not protect the CHO cells from BAA induced DNA damage, 
although there appeared to be an indication of some protective effect emerging at the highest 
NAC concentration (Figure 4.5). NAC can directly scavenge electrophiles or provide an 
extracellular source of cysteine to enhance production of GSH [35]. It cannot be determined 
form these experiments if NAC or GSH are directly interacting with BAN and BAM or 
neutralizing ROS generated from some other pathway, but, in either case, the differential effect 
of NAC on BAN and BAM, vs. BAA induced genotoxicity suggest these electrophilic DBPs 
target different intracellular nucleophiles.  
 
Cumulative Toxicity Among Monobrominated-DBP Binary Mixtures  
Because they have different cellular targets, it is unclear how these DBPs would interact 
in mixtures, while the proposed initiating events are different; they all potentially converge at 
disruption of ER Ca
2+
 homeostasis [31, 34]. To investigate how these chemicals interact we 
prepared binary mixtures and measured genotoxicity with SCGE as an endpoint. Mixtures 
included sham mixtures (two “low” concentrations of the same chemical to generate a single 
“high” concentration) or mixtures of two chemicals at the defined “low” concentrations. For 
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BAN, and BAM the “low” and “high” concentrations were 30 µM and 60 µM, respectively; for 
BAA the “low” and “high” concentrations were 125 µM, and 250 µM. 
 Exposures to 30 µM BAN (8.9 % tail DNA) was less genotoxic than 30 µM BAM (30.4 
% tail DNA); the mixture of 30 µM BAN plus 30 µM BAM was less genotoxic (60.1 % tail 
DNA) than 60 µM of either BAN or BAM (71.3, and 76.4 % tail DNA, respectively) but 153.3% 
of the sum of the BAN + BAM low concentrations (39.2 % tail DNA) (Figure 4.6). 
 The mean % tail DNA value (29.0%) resulting from binary mixtures of 30 µM BAN and 
125 µM BAA was similar to the sum of the two individual % tail DNA values generated from 
the low concentrations of BAN and BAA (31.7 %). The mixture was not statistically different 
from 125 µM BAA (21.3 % tail DNA; P ≤ 0.078) or 250 µM BAA (34.1 % tail DNA; P ≤ 
0.273), but greater than 30 µM BAN (10.4 % tail DNA; P ≤ 0.001) and less than 60 µM BAN 
(70.9 % tail DNA; P ≤ 0.001) (Figure 4.7).  
The mean % tail DNA resulting from binary mixtures of 30 µM BAM and 125 µM BAA 
(60.9 % tail DNA) was similar to the sum (63.9% tail DNA) of 30 µM BAM (34.5 % Tail DNA) 
and 125 µM BAA (29.3 % tail DNA). The mixture was more genotoxic than either of the 
individual BAA concentrations and 30 µM BAM, but generated less DNA damage than 60 µM 
BAM (78.9 % tail DNA) (P ≤ 0.001 in each case) (Figure 4.8).  
Evaluating combined toxicity was used to determine if SN2 reactive soft electrophilic 
compounds shared a similar toxic mechanism; where it was suggested that purely additive 
toxicities indicated a single shared mechanism [21, 24, 25]. Of the binary mixtures investigated 
in this study BAM + BAA and BAN + BAA seemed to produce an effect equal to the sum of the 
individual exposures. Although these data agreed with a previous report of additivity among 
monoHANs and ethyl halogenated acetates (chemicals structurally related to the monoHAAs), 
 116 
 
this phenomenon was somewhat peculiar, as the two compounds in each mixture have different 
proposed modes of action, and BAN and BAM, both of which deplete cellular GSH, had a 
greater than additive genotoxic effect.  While the proposed cellular targets are different (GAPDH 
for BAA, and GSH for BAN and BAM) each of the compounds are structurally similar. Alkyl 
halide functional groups (C-X, where X is chlorine, bromine or iodine), due to the electron 
withdrawing effect of the halogen and the subsequent partial positive charge (lack of electron 
density) on the carbon atom are SN2 reactive electrophiles. Electrophilic compounds pose a 
threat to living systems. By reacting with biological nucleophiles, i.e. nitrogen or oxygen atoms 
in DNA, or nitrogen, oxygen, and sulfur atoms in proteins, electrophiles can disrupt the function 
of proteins or damage DNA leading to mutations and or cell death. The hard/soft designation 
assigned acids and bases can be used to predict reactivity of electro/nucleophile pairs; in general, 
hard-hard or soft-soft pairs are more reactive than a hard-soft combination [36]. Sulfur 
containing thiols (R-SH) or thiolate anion (R-S
-
), being the softest of the biological nucleophiles, 
were most reactive with soft electrophiles [37]. The sulfhydryl (SH) groups in cysteine residues 
play a critical role in sensing and eliminating electrophilic and oxidative stress in living systems 
[38]. Glutathione (GSH) and thioredoxin utilize cysteine residues to bind electrophilic molecules 
in an attempt to detoxify the cellular environment and prevent accumulation of ROS or 
aggregation of proteins during oxidative stress [38]. Additionally the transcription factor Nrf2 is 
dependent on cysteine residues in its regulator Keap1 for its activation [39]. Electrophilic or 
oxidative stress causes intermolecular S-S bridge changing the conformation of Keap1 dimers 
[40, 41], which in turn releases Nrf2 allowing it to translocate to the nucleus where it binds to 
antioxidant response elements (ARE), cis acting elements in DNA that regulate the production of 
a host of antioxidant enzymes including those that synthesize GSH [42].  
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Because GSH plays a critical role in maintaining redox balance, compounds that deplete 
GSH lead to oxidative stress, protein aggregation via intermolecular S-S bonding, and ultimately 
toxicity. Included among the proteins that aggregate during oxidative stress is GAPDH [43]; 
oxidation or poly (ADP-ribosyl)ation of GAPDH’s active site cysteine by poly (ADP-ribose) 
polymerase (PARP), which is activated by DNA strand breaks, also inactivate the glycolytic 
function of the enzyme [44]. Embryonic GAPDH was also inhibited by oxidative stress and 
played an important role in hydroxyurea induced teratogenesis [45].   
Alternatively inhibition of GAPDH causes a rapid depletion of cellular ATP [46] which 
is required to generate GSH [47]. Disruption of glycolysis also inhibited SERCA activity [30, 
31] which led to increased [Ca
2+
]i and generated ROS and lipid peroxidation [32, 33] which in 
turn depleted GSH [47]. So, while the exact same ROS-inducing mechanisms might not exist 
among HANs, HAMs, and HAAs, they are each soft electrophiles that target sulfhydryl groups, 
and disruption of glycolysis and depletion of cellular GSH feedback upon each other to disrupt 
Ca
2+
 homeostasis and generate oxidative stress. These findings provide an important step in 
considering the cumulative effect of multiple DBPs, whereas no individual DBP is likely to be 
generated at a toxic concentration, many soft electrophilic compounds are generated during the 
disinfection process and could act in concert to disrupt intracellular Ca
2+
 homeostasis and 
generate oxidative stress, which might then lead to cancer and adverse pregnancy outcomes.   
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Figure 4.1. CHO cell genomic DNA damage after 4 h treatment with monoHAA ± BHA. Data 
for each monoHAA are presented as percentages of their respective positive control values.  
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Figure 4.2. CHO cell genomic DNA damage after 4 h treatment with monoHAA ± BAPTA-AM. 
Data for each monoHAA are presented as percentages of their respective positive control values. 
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Figure 4.3. CHO cell genomic DNA damage after 4 h treatment with EMS ± BAPTA-AM or 
H2O2 ± BAPTA-AM. Data for EMS and H2O2 are presented as percentages of their respective 
positive control values. 
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Figure 4.4. CHO cell genomic DNA damage after 4 h treatment with DBP ± BAPTA-AM. Data 
for each DBP are presented as percentages of their respective positive control values. 
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Figure 4.5. CHO cell genomic DNA damage after 4 h treatment with DBP ± NAC. Data for each 
DBP are presented as percentages of their respective positive control values. 
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Figure 4.6. CHO cell genomic DNA damage after 4 h treatment with BAN, BAM or BAN + 
BAM. For BAN and BAM Low concentration = 30 µM, High concentration = 60 µM, and the 
Low + Low concentration is a mixture of 30 µM BAN and 30 µM BAM. 
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Figure 4.7. CHO cell genomic DNA damage after 4 h treatment with BAN, BAA or BAN + 
BAA. For BAN and BAA Low concentration = 30 µM and 125 µM respectively, High 
concentration = 60 µM and 250 µM respectively, and the Low + Low concentration is a mixture 
of 30 µM BAN and 125 µM BAA. 
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Figure 4.8. CHO cell genomic DNA damage after 4 h treatment with BAM, BAA or BAM + 
BAA. For BAM and BAA Low concentration = 30 µM and 125 µM respectively, High 
concentration = 60 µM and 250 µM respectively, and the Low + Low concentration is a mixture 
of 30 µM BAM and 125 µM BAA. 
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CHAPTER 5:  CONCLUSIONS 
 
Genotoxicity induced by the monoHAAs, followed the pattern of descending toxicity 
IAA > BAA > CAA. This pattern was shared by the alkylation potential of these compounds. 
Based on these observations a working hypothesis was formed, in which the monoHAAs 
damaged DNA by direct alkylation. However, experiments in which antioxidants reduced the 
genotoxicity and mutagenicity of IAA and toxicogenomic analyses that showed cells treated with 
the monoHAAs were responding to double strand breaks suggested that ROS, rather than direct 
alkylation was responsible for their genotoxicity. Based on a review of the neurotoxicology 
literature involving IAA, disruption of glycolysis via the inhibition of GAPDH emerged as a 
possible pathway through which DNA could be damaged in a manner that fit well with the 
emerging data. The research described in this dissertation was conducted with the aim of 
systematically testing a new working hypothesis in which monoHAAs inhibit glycolysis, 
increase intracellular Ca
2+
, and generate ROS which are ultimately responsible for genotoxicity.   
The ability of the monoHAAs to interact directly with DNA isolated from the cellular 
environment was investigated. While each of the monoHAAs generated DNA damage in treated 
cells, acellular DNA was not vulnerable to alkylation by these compounds. This finding 
solidified growing doubts that direct alkylation was the mode of action by which the monoHAAs 
were damaging DNA, and suggested some cellular target(s) remained to be discovered. A 
comparative study evaluating the effect of each monoHAA on GAPDH activity showed that the 
ability to inhibit this enzyme closely followed the pattern of toxicity, where IAA > BAA > CAA. 
A correlation analysis revealed that GAPDH inhibition potential was strongly associated with 
toxicological endpoints including cytotoxicity, genotoxicity, mutagenicity, and teratogenicity.  
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Inhibition of glycolysis disrupts Ca
2+
 homeostasis which can generate ROS. Thus the 
working hypothesis grew to include a link between inhibition of GAPDH and formation of ROS 
involving disruption of Ca
2+
. A series of studies were conducted to investigate if each of the 
monoHAAs could generate ROS in non-neuronal cell lines, and if they were involved in 
damaging DNA. Each of the monoHAAs activated ARE driven transcription of a reporter gene 
and modulated transcription levels of oxidative stress responsive genes, two sensitive indicators 
of oxidative stress.  BHA mitigated the genotoxicity of each of the monoHAAs and provided 
evidence that DNA damage was resulting from ROS. Buffering the cytosolic Ca
2+
 levels with 
BAPTA-AM also reduced DNA damage induced by the monoHAAs.  
These data helped to solidify the working hypothesis (Figure 5.1), and strongly suggested 
that a cascade of events leading to genomic DNA damage could be initiated by the inhibition of 
GAPDH. However, the goal of identifying the toxic mechanisms for individual DBPs should 
ultimately be to understand how multiple chemicals can interact to generate toxicity. DBP 
exposure was linked to adverse health and pregnancy outcomes, but because many individual 
DBPs are generated in small, likely non-toxic amounts, understanding possible interactions 
among individual chemicals might provide a better understanding of the cumulative effect of 
exposure. With this goal in mind, another set of experiments was designed to investigate the 
genotoxicity of defined component DBP mixtures. BAN and BAM were chosen because 
oxidative stress and disruption of Ca
2+
 homeostasis were associated with their toxicities. 
Buffering cytosolic Ca
2+
 levels with BAPTA-AM or supplementing the GSH precursor NAC 
significantly attenuated genotoxicity induced by BAN and BAM; these data showed that Ca
2+
 
and ROS were involved in DNA damage generated by these compounds. Combining BAA with 
either BAN or BAM produced an additive genotoxic effect. This finding was interesting in that 
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while each of BAA, BAN, and BAM share disruption of Ca
2+
 homeostasis and oxidative stress in 
their toxic cascades, the initiating events are different (GSH depletion for BAN and BAM; 
inhibition of GAPDH for BAA). The additive genotoxic effect of these compounds suggested 
that multiple compounds could converge through different pathways to generate toxicity. The 
monoHAAs, BAN, and BAM are soft electrophiles that react preferentially with soft 
nucleophiles, which, in biological systems, include cysteine thiol moieties. Cysteine thiols play 
an important role in redox regulation; an assault of soft electrophiles could overwhelm the 
cellular redox potential and generate oxidative stress through multiple pathways leading to 
cancer, neurodegenerative disease, or any of the many associated pathologies.   
Further investigation of the individual mechanisms of toxicity and interactions among 
DBPs will provide the necessary information to mitigate the health and reproductive risks 
associated with disinfected water. By identifying the mechanisms leading to adverse health and 
reproductive outcomes water treatment processes can be engineered to either eliminate the DBP 
precursors in the source water or target specific DBPs or DBP classes for removal from the 
distribution systems. Additionally, biomarkers of oxidative stress could be used to mark DBP 
exposures and assays could be developed to measure the overall effect of disinfected water so 
that Federal regulations and water treatment processes can be focused on reducing oxidative 
stress as a way to prevent adverse health and reproductive outcomes associated with DBPs.  
 
The major findings presented within this dissertation include: 
• MonoHAAs initiate a genotoxic cascade by inhibiting glycolysis, which disrupts Ca2+ 
homeostasis and generates oxidative stress. 
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• BAN and BAM deplete cellular GSH disrupt Ca2+ homeostasis and generates oxidative 
stress. 
• DBPs that generate oxidative stress have a cumulative genotoxic effect.  
• Transcription of COX-2 was upregulated by 4 h monoHAA exposures; this uncovered an 
important link between cancer and DBP exposure. 
• Two possible Ca2+ dependent sources of ROS were identified in NOX5 and COX-2. 
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Figure 
 
 
 
 
 
 
 
Figure 5.1. Genotoxic cascade initiated by monoHAA induced inhibition of GAPDH.  
 
 
 
 
